data_2kht_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kht _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.566 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 7.4 m . . . . . 0 N--CA 1.469 0.484 0 CA-C-O 121.187 0.517 . . . . 0.0 110.461 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -92.63 -168.14 1.9 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.307 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.443 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 0.7 OUTLIER -85.41 -174.67 5.32 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.139 -179.461 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -94.28 112.27 24.05 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-O 121.246 0.546 . . . . 0.0 109.829 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.65 ' O ' ' N ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -136.67 139.33 28.87 Favored Pre-proline 0 N--CA 1.439 -0.993 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.299 179.079 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -46.04 72.65 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.685 2.257 . . . . 0.0 112.685 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.65 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -143.33 -163.31 1.62 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.44 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.513 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 29.9 p -58.63 69.81 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.609 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.586 ' N ' ' O ' ' A' ' 8' ' ' ALA . 86.6 mt -77.75 -21.12 13.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.3 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.445 ' O ' ' O ' ' A' ' 10' ' ' ILE . . . -54.01 -164.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.608 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.8 -59.44 2.58 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.504 ' OE1' ' N ' ' A' ' 13' ' ' GLU . 58.0 mp0 -143.76 149.62 37.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.024 0.44 . . . . 0.0 110.562 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -127.35 116.56 20.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.079 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.518 ' NE ' ' CH2' ' A' ' 26' ' ' TRP . 14.3 tpt180 -78.61 137.85 38.05 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.259 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -84.84 -40.66 16.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.682 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.91 155.22 52.72 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.3 p -126.82 142.28 51.59 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.658 0.266 . . . . 0.0 110.373 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.518 ' SG ' ' O ' ' A' ' 19' ' ' CYS . 12.9 p -102.46 119.23 38.47 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.217 0.532 . . . . 0.0 110.394 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.4 mm -90.23 96.8 6.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.156 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -146.89 106.09 3.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.107 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 40.2 tp60 63.6 14.29 7.98 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.051 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.23 33.69 19.54 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.494 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 96.1 mtt-85 -131.06 121.06 24.33 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.176 0.512 . . . . 0.0 110.574 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.0 mt -87.38 167.1 14.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.41 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.605 ' O ' ' CG ' ' A' ' 26' ' ' TRP . 1.2 p-90 -113.73 109.94 19.37 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.572 0.701 . . . . 0.0 111.268 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -95.67 159.69 14.86 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -75.31 102.13 4.97 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.098 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.513 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 7.9 t -122.42 122.8 39.84 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.991 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.566 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 44.4 m . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 118.112 -0.947 . . . . 0.0 110.372 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.575 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 20.6 p . . . . . 0 CA--C 1.52 -0.208 0 CA-C-O 120.681 0.277 . . . . 0.0 110.538 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.48 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 7.9 p90 -139.45 66.18 1.41 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.196 0.522 . . . . 0.0 111.15 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -154.49 174.53 14.79 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.396 177.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 70.9 ttp85 -99.43 114.74 27.85 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 121.67 0.748 . . . . 0.0 109.161 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.656 ' O ' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -137.19 133.11 18.26 Favored Pre-proline 0 C--N 1.305 -1.332 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 -179.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -47.19 85.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.302 -1.881 0 CA-C-N 119.725 0.938 . . . . 0.0 110.691 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.656 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -150.08 -164.83 2.11 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.491 -178.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 29.1 p -56.66 68.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.354 0.409 . . . . 0.0 111.162 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.598 ' N ' ' O ' ' A' ' 8' ' ' ALA . 4.9 mm -69.6 -25.44 28.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.753 0.311 . . . . 0.0 110.393 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.72 171.54 13.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.501 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.03 -17.79 58.61 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.548 ' OE2' ' CG ' ' A' ' 28' ' ' PHE . 72.6 tt0 -161.0 160.79 31.1 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 83.0 mmt-85 -103.39 157.26 17.15 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.133 0.492 . . . . 0.0 111.095 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -84.04 140.24 31.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.85 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.542 ' CD2' ' N ' ' A' ' 17' ' ' GLY . 84.8 t80 -146.65 -95.33 0.09 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.621 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.542 ' N ' ' CD2' ' A' ' 16' ' ' TYR . . . -60.56 77.04 0.01 OUTLIER Glycine 0 CA--C 1.522 0.499 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.537 ' N ' ' O ' ' A' ' 16' ' ' TYR . 60.1 p -79.9 164.08 23.82 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.894 -0.323 . . . . 0.0 111.324 -178.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.44 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 14.1 p -118.71 126.18 51.32 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.207 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.414 ' C ' ' CD1' ' A' ' 21' ' ' TYR . 5.4 mp -86.62 97.71 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.418 ' C ' ' N ' ' A' ' 23' ' ' GLY . 67.6 m-85 -146.35 143.82 29.36 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.438 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 50.17 15.61 0.2 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.8 0.333 . . . . 0.0 110.586 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.418 ' N ' ' C ' ' A' ' 21' ' ' TYR . . . 76.13 25.67 65.89 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -128.26 140.95 51.61 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.986 0.422 . . . . 0.0 110.944 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.574 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 2.2 mm? -89.62 157.85 17.86 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.529 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.541 ' CE3' ' O ' ' A' ' 17' ' ' GLY . 1.7 t90 -102.53 114.26 28.32 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.513 ' O ' ' CD1' ' A' ' 26' ' ' TRP . . . -89.42 152.69 21.35 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 177.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.548 ' CG ' ' OE2' ' A' ' 13' ' ' GLU . 0.8 OUTLIER -75.88 102.65 5.62 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 118.685 -1.206 . . . . 0.0 108.718 -178.547 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.44 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 12.9 t -108.0 153.83 22.52 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.318 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.575 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 2.6 m . . . . . 0 C--O 1.219 -0.507 0 CA-C-O 117.843 -1.075 . . . . 0.0 110.425 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.61 ' SG ' ' CE2' ' A' ' 28' ' ' PHE . 10.7 t . . . . . 0 CA--C 1.519 -0.247 0 CA-C-O 120.981 0.42 . . . . 0.0 110.769 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.531 ' CD2' ' O ' ' A' ' 4' ' ' CYS . 56.8 t80 -102.99 151.5 22.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.346 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.568 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 2.7 m -88.17 154.08 20.73 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.43 ' HG3' ' H ' ' A' ' 6' ' ' ILE . 3.5 tpt180 -138.06 174.17 10.85 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 122.029 0.919 . . . . 0.0 111.99 -178.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.628 ' O ' ' N ' ' A' ' 8' ' ' ALA . 1.9 pt -99.73 162.14 22.11 Favored Pre-proline 0 N--CA 1.44 -0.954 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 177.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -47.86 76.27 0.01 OUTLIER 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 122.113 1.875 . . . . 0.0 113.813 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.628 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -175.02 110.36 0.12 Allowed 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.16 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.552 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 55.8 m -70.46 70.3 0.42 Allowed 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.534 ' N ' ' O ' ' A' ' 8' ' ' ALA . 66.2 mt -66.28 -42.82 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-N 114.154 -1.384 . . . . 0.0 110.166 -178.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.22 -39.36 17.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.54 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.73 78.76 0.85 Allowed Glycine 0 CA--C 1.529 0.921 0 N-CA-C 111.815 -0.514 . . . . 0.0 111.815 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.516 ' O ' ' SG ' ' A' ' 9' ' ' CYS . 2.5 mm-40 -162.18 -179.18 6.86 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.987 0.422 . . . . 0.0 110.098 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -103.99 136.41 43.69 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.751 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.7 ptt-85 -75.49 132.08 40.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.445 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.423 ' H ' ' HB3' ' A' ' 28' ' ' PHE . 29.8 m-85 -148.55 -103.29 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.09 65.79 1.22 Allowed Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.386 -1.085 . . . . 0.0 110.386 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 26' ' ' TRP . 8.9 t -79.43 163.94 24.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.963 0.411 . . . . 0.0 110.746 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.568 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 2.3 m -101.4 154.07 19.12 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.786 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.6 mm -96.0 116.29 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 120.957 0.408 . . . . 0.0 110.577 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.411 ' C ' ' H ' ' A' ' 23' ' ' GLY . 43.1 m-85 -121.98 133.23 54.82 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.27 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 52.32 13.74 0.31 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.728 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 21' ' ' TYR . . . 81.79 4.44 90.33 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -92.89 146.03 23.94 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.52 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 3.4 mm? -76.86 136.24 38.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.119 0.485 . . . . 0.0 110.342 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.435 ' O ' ' OG1' ' A' ' 18' ' ' THR . 3.8 m95 -111.59 143.89 41.72 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.597 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -90.42 118.53 29.97 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.61 ' CE2' ' SG ' ' A' ' 2' ' ' CYS . 26.0 t80 -76.99 100.03 5.49 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.552 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 1.3 m -130.13 126.28 37.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.46 -1.245 . . . . 0.0 109.43 -178.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.588 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 69.1 m . . . . . 0 C--O 1.218 -0.57 0 CA-C-O 118.101 -0.952 . . . . 0.0 111.556 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.581 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 16.7 p . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.655 0.264 . . . . 0.0 110.303 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.503 ' O ' ' CD2' ' A' ' 3' ' ' TYR . 18.8 p90 -139.61 68.63 1.37 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.485 0.659 . . . . 0.0 110.773 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.478 ' C ' ' CD1' ' A' ' 26' ' ' TRP . 0.8 OUTLIER -151.28 179.14 8.57 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.303 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.474 HH11 ' CB ' ' A' ' 27' ' ' ALA . 57.7 ttt85 -95.59 122.36 38.26 Favored 'General case' 0 CA--C 1.489 -1.396 0 CA-C-O 122.485 1.136 . . . . 0.0 109.672 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.69 ' C ' ' H ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -104.37 158.24 32.36 Favored Pre-proline 0 N--CA 1.416 -2.174 0 N-CA-C 102.58 -3.119 . . . . 0.0 102.58 176.75 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -61.82 24.66 0.05 OUTLIER 'Trans proline' 0 C--N 1.274 -3.346 0 C-N-CA 121.08 1.187 . . . . 0.0 111.985 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.69 ' H ' ' C ' ' A' ' 6' ' ' ILE . . . -155.27 108.91 2.83 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.544 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.441 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 1.0 OUTLIER -62.85 99.29 0.15 Allowed 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 117.581 -1.648 . . . . 0.0 106.827 178.12 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.421 ' N ' ' O ' ' A' ' 8' ' ' ALA . 96.3 mt -65.08 -43.46 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.317 -176.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.52 -22.12 51.65 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.346 -0.541 . . . . 0.0 111.147 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.71 30.48 76.35 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.551 ' OE1' ' CD1' ' A' ' 28' ' ' PHE . 83.1 mt-10 -100.79 -175.82 3.0 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.367 0.603 . . . . 0.0 111.358 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 85.8 mtp180 -101.03 143.5 31.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.765 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.495 ' H ' ' HD2' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -68.41 142.13 55.49 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.297 -179.352 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.537 ' CD2' ' N ' ' A' ' 17' ' ' GLY . 70.6 t80 -148.63 -99.15 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.886 0.374 . . . . 0.0 110.868 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.537 ' N ' ' CD2' ' A' ' 16' ' ' TYR . . . -79.43 68.51 3.15 Favored Glycine 0 CA--C 1.52 0.347 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.4 ' CG2' ' O ' ' A' ' 26' ' ' TRP . 6.3 p -80.49 165.33 22.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.091 0.472 . . . . 0.0 111.991 -178.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.417 ' H ' ' HB3' ' A' ' 26' ' ' TRP . 9.4 p -100.03 139.22 36.01 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.126 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 21.0 mm -78.39 122.85 34.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.998 0.428 . . . . 0.0 110.316 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.445 ' C ' ' H ' ' A' ' 23' ' ' GLY . 86.5 t80 -153.53 128.69 9.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.582 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 43.2 tp60 51.87 12.39 0.19 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.07 0.462 . . . . 0.0 110.213 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 21' ' ' TYR . . . 86.39 -2.26 87.44 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -98.26 135.1 40.37 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 76.1 mt -80.92 138.33 36.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.157 0.503 . . . . 0.0 110.562 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.701 ' CD1' ' O ' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -77.78 111.72 13.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.861 179.146 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.701 ' O ' ' CD1' ' A' ' 26' ' ' TRP . . . -66.39 149.14 50.84 Favored 'General case' 0 C--O 1.218 -0.605 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.551 ' CD1' ' OE1' ' A' ' 13' ' ' GLU . 3.0 t80 -73.24 104.07 4.16 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 118.691 -1.204 . . . . 0.0 110.027 -178.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.441 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 12.7 m -122.29 164.85 17.18 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 113.382 -1.735 . . . . 0.0 109.292 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.581 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 5.2 m . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.01 -0.995 . . . . 0.0 111.027 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.553 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 8.0 t . . . . . 0 CA--C 1.512 -0.486 0 CA-C-O 121.315 0.579 . . . . 0.0 110.988 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.552 ' N ' ' SG ' ' A' ' 30' ' ' CYS . 58.6 m-85 -131.45 151.58 51.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.248 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.584 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 56.7 m -87.78 -175.13 5.04 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.839 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 51.4 ttt85 -92.11 114.72 27.33 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 122.743 1.259 . . . . 0.0 111.065 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.6 ' O ' ' N ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -139.44 129.95 14.49 Favored Pre-proline 0 N--CA 1.426 -1.645 0 N-CA-C 103.268 -2.864 . . . . 0.0 103.268 176.097 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -47.4 90.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.295 -2.257 0 CA-C-N 121.002 1.394 . . . . 0.0 110.893 -177.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.6 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -146.85 -161.44 1.33 Allowed 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.792 -177.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.57 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 28.2 p -57.52 76.76 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.356 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.575 ' N ' ' O ' ' A' ' 8' ' ' ALA . 52.5 mt -68.66 -18.54 23.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.59 -164.67 1.16 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.028 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.06 -102.96 2.44 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -100.78 167.07 10.54 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 85.1 mtm-85 -101.3 162.97 12.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.09 0.472 . . . . 0.0 110.921 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -67.29 134.56 51.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.874 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.48 ' N ' ' SG ' ' A' ' 2' ' ' CYS . 88.0 t80 -85.74 -15.56 41.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.292 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 178.03 110.02 0.26 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.489 ' OG1' ' CD1' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -79.25 144.22 34.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.819 0.343 . . . . 0.0 110.63 -179.878 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.584 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 25.8 p -133.29 118.43 18.53 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.103 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.5 mt -87.98 139.15 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 CA-C-O 121.194 0.521 . . . . 0.0 110.877 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -149.47 115.15 5.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.493 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 50.56 33.77 8.52 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.699 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.69 36.03 7.03 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.784 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 60.7 ttm-85 -90.41 132.38 35.65 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.238 0.542 . . . . 0.0 110.719 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.526 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 3.6 mm? -95.64 163.15 13.32 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.538 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.489 ' CD1' ' OG1' ' A' ' 18' ' ' THR . 61.8 p-90 -122.16 138.91 54.3 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 122.074 0.94 . . . . 0.0 110.874 178.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -115.58 160.41 20.02 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 113.695 -1.593 . . . . 0.0 107.974 178.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.464 ' O ' ' O ' ' A' ' 10' ' ' ILE . 85.7 m-85 -75.22 100.76 4.42 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 178.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.57 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 8.6 t -139.01 -173.25 3.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.173 -176.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.553 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 2.7 m . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.897 -1.049 . . . . 0.0 110.626 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 5.6 p . . . . . 0 CA--C 1.522 -0.134 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.411 ' C ' ' CD1' ' A' ' 26' ' ' TRP . 42.1 m-85 -125.37 66.91 1.14 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.89 0.376 . . . . 0.0 110.641 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.611 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -153.37 173.68 15.33 Favored 'General case' 0 C--O 1.214 -0.764 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.691 HH11 ' NH2' ' A' ' 15' ' ' ARG . 62.4 ttp180 -100.09 111.47 23.76 Favored 'General case' 0 CA--C 1.479 -1.782 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.561 ' C ' ' H ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -108.39 158.78 32.95 Favored Pre-proline 0 C--N 1.299 -1.605 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 178.948 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -48.9 -6.18 0.05 OUTLIER 'Trans proline' 0 C--N 1.28 -3.069 0 C-N-CA 120.76 0.974 . . . . 0.0 112.193 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.561 ' H ' ' C ' ' A' ' 6' ' ' ILE . . . -127.41 105.79 8.76 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.299 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.621 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 1.7 p 155.25 5.19 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.1 mm -66.73 -42.51 89.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 C-N-CA 119.624 -0.831 . . . . 0.0 109.112 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -101.76 154.41 18.93 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.881 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.83 6.2 85.54 Favored Glycine 0 N--CA 1.466 0.649 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.55 ' CG ' ' O ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER -163.22 -176.8 5.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.815 0.34 . . . . 0.0 110.588 -179.002 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -131.82 152.67 50.83 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.682 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.691 ' NH2' HH11 ' A' ' 5' ' ' ARG . 42.0 ttm180 -86.21 100.43 12.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.808 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -102.08 -101.7 0.27 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.88 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.533 ' O ' ' CE3' ' A' ' 26' ' ' TRP . . . -59.22 112.32 4.12 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.414 ' HA ' ' H ' ' A' ' 26' ' ' TRP . 0.1 OUTLIER -102.44 123.8 46.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.951 0.405 . . . . 0.0 110.419 -179.488 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.497 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 7.3 p -101.72 131.69 47.85 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.029 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 15.3 mm -84.65 113.82 23.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 C-N-CA 120.224 -0.59 . . . . 0.0 109.789 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -149.13 114.88 5.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.172 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 49.1 21.42 0.49 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.49 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.83 29.53 26.02 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' A' ' 19' ' ' CYS . 99.7 mtt180 -124.88 122.24 36.82 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.819 0.342 . . . . 0.0 110.932 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.4 mt -80.27 162.56 24.54 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.736 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.533 ' CE3' ' O ' ' A' ' 17' ' ' GLY . 1.7 t90 -97.02 116.5 29.33 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.026 0.441 . . . . 0.0 110.022 178.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.446 ' O ' ' CD1' ' A' ' 26' ' ' TRP . . . -96.53 151.73 19.3 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.427 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 47.0 t80 -75.94 101.07 5.05 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 118.736 -1.186 . . . . 0.0 108.612 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.621 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 61.4 m -96.16 144.12 26.68 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.869 -178.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 2.6 m . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.399 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.572 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 4.9 m . . . . . 0 CA--C 1.503 -0.863 0 CA-C-O 121.622 0.725 . . . . 0.0 110.67 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -93.41 -171.49 2.65 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.566 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 5.8 t -87.96 -176.92 5.63 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' ' 25' ' ' LEU . 72.5 ttt180 -94.89 111.99 23.74 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 122.333 1.063 . . . . 0.0 109.894 -178.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.558 ' O ' ' N ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -126.94 131.47 23.89 Favored Pre-proline 0 C--N 1.304 -1.394 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 177.383 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -46.93 95.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.301 -1.941 0 CA-C-N 120.894 1.355 . . . . 0.0 110.086 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.635 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -153.58 -164.35 1.87 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.008 -177.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.555 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 26.9 p -54.37 75.97 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.635 ' N ' ' O ' ' A' ' 8' ' ' ALA . 8.7 tp -69.77 -39.71 78.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.35 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.16 172.14 0.87 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.477 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.95 -24.34 28.98 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 -162.3 153.97 18.46 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 90.9 mtm-85 -103.25 155.83 18.16 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.018 0.437 . . . . 0.0 110.7 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 53.3 ptt85 -87.63 140.56 29.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.937 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -108.1 -65.15 1.14 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.092 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 26' ' ' TRP . . . -98.57 166.28 21.67 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.69 124.52 22.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.918 0.39 . . . . 0.0 110.663 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.566 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 14.1 p -101.09 130.04 47.07 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.432 HD13 HG22 ' A' ' 20' ' ' ILE . 11.0 mm -95.33 116.32 36.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.016 0.436 . . . . 0.0 109.943 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.408 ' C ' ' H ' ' A' ' 23' ' ' GLY . 90.7 t80 -166.45 126.87 1.65 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.434 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 55.69 12.54 0.84 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.176 0.512 . . . . 0.0 109.858 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.408 ' H ' ' C ' ' A' ' 21' ' ' TYR . . . 83.89 26.09 42.89 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.648 -0.581 . . . . 0.0 111.648 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.466 ' O ' ' O ' ' A' ' 19' ' ' CYS . 90.4 mtm180 -118.14 137.25 53.09 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.729 0.3 . . . . 0.0 110.634 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.573 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 0.7 OUTLIER -96.87 164.72 12.43 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.775 -179.292 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.478 ' CZ2' ' O ' ' A' ' 2' ' ' CYS . 25.8 t-105 -101.39 109.23 21.04 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 121.105 0.478 . . . . 0.0 111.167 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -114.83 147.72 39.47 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 176.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.404 ' CD2' ' SG ' ' A' ' 2' ' ' CYS . 9.3 m-85 -78.63 101.12 7.3 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.555 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 8.4 t -117.83 123.48 46.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.751 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.572 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 0.9 OUTLIER . . . . . 0 C--O 1.221 -0.437 0 CA-C-O 117.809 -1.091 . . . . 0.0 109.802 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.58 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 93.1 m . . . . . 0 CA--C 1.519 -0.239 0 CA-C-O 121.159 0.504 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -92.55 152.59 19.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.768 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 3.5 m -88.24 151.2 22.82 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.425 ' O ' ' N ' ' A' ' 27' ' ' ALA . 2.4 tpt180 -130.69 173.44 10.91 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 122.149 0.976 . . . . 0.0 111.363 -178.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.648 ' O ' ' N ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER -100.74 164.37 16.29 Favored Pre-proline 0 C--N 1.312 -1.03 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 177.059 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -46.2 75.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.301 -1.935 0 C-N-CA 122.467 2.111 . . . . 0.0 114.057 -176.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.648 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -174.91 109.16 0.11 Allowed 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 113.551 -1.659 . . . . 0.0 108.61 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.556 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 5.1 m -72.0 68.33 0.68 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.461 ' N ' ' O ' ' A' ' 8' ' ' ALA . 57.6 mt -68.88 -22.74 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-N 113.991 -1.459 . . . . 0.0 110.743 -178.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.45 -43.69 14.38 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.236 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.5 41.67 1.12 Allowed Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.542 ' OE1' ' SG ' ' A' ' 30' ' ' CYS . 12.5 pt-20 -146.78 -173.91 4.34 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 81.5 mtm-85 -101.04 149.48 23.89 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.003 0.43 . . . . 0.0 112.137 -178.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 47.0 ptt85 -91.09 128.66 37.0 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.859 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 91.9 t80 -147.22 -72.48 0.22 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.18 81.42 1.59 Allowed Glycine 0 CA--C 1.524 0.609 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.8 t -110.03 158.44 18.27 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.183 0.516 . . . . 0.0 110.647 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 0.7 OUTLIER -100.71 148.91 24.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.26 179.673 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.6 mm -94.27 119.0 41.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.019 0.437 . . . . 0.0 110.403 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -130.65 142.01 50.43 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.871 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 56.58 12.29 1.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.604 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.27 -1.16 71.67 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -93.09 149.99 20.84 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.641 0.258 . . . . 0.0 110.52 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.7 mp -77.48 139.23 39.59 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.986 0.422 . . . . 0.0 110.315 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -109.63 142.24 41.04 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.668 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 5' ' ' ARG . . . -87.22 114.36 23.77 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 175.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -75.82 99.87 4.58 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 118.062 -1.455 . . . . 0.0 107.19 -179.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.556 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 1.2 m -141.35 123.62 15.68 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 113.515 -1.675 . . . . 0.0 108.932 -178.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.58 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 46.0 m . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 117.895 -1.05 . . . . 0.0 111.605 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.573 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 70.7 m . . . . . 0 N--CA 1.464 0.23 0 CA-C-O 120.824 0.345 . . . . 0.0 110.845 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.478 ' CD2' ' O ' ' A' ' 4' ' ' CYS . 58.7 t80 -92.4 152.18 19.86 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.56 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 33.6 m -88.48 148.52 24.13 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.823 0.344 . . . . 0.0 110.92 -178.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.421 ' HG3' ' H ' ' A' ' 6' ' ' ILE . 1.9 tpt180 -156.09 178.03 10.75 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.86 0.838 . . . . 0.0 111.041 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.662 ' O ' ' N ' ' A' ' 8' ' ' ALA . 0.7 OUTLIER -94.84 166.75 14.41 Favored Pre-proline 0 N--CA 1.439 -1.012 0 N-CA-C 103.318 -2.845 . . . . 0.0 103.318 177.216 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -50.86 54.88 0.02 OUTLIER 'Trans proline' 0 N--CA 1.507 2.317 0 C-N-CA 122.425 2.083 . . . . 0.0 115.88 -176.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.662 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -175.14 101.82 0.08 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.77 -0.196 . . . . 0.0 110.808 177.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.621 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 35.4 t 151.36 -8.24 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.547 ' C ' ' H ' ' A' ' 12' ' ' GLY . 8.3 mt -68.3 125.37 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 CA-C-N 114.277 -1.328 . . . . 0.0 109.585 -177.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.24 12.77 0.85 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.547 ' H ' ' C ' ' A' ' 10' ' ' ILE . . . 114.09 80.11 0.92 Allowed Glycine 0 CA--C 1.527 0.812 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.041 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -161.88 168.42 23.04 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 85.1 mmt-85 -103.78 158.82 16.13 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.962 0.411 . . . . 0.0 111.026 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.499 ' HA ' ' H ' ' A' ' 28' ' ' PHE . 33.2 ptt180 -70.71 127.65 33.38 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.492 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.503 ' CD2' ' N ' ' A' ' 17' ' ' GLY . 90.4 t80 -147.41 -91.16 0.09 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.574 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.503 ' N ' ' CD2' ' A' ' 16' ' ' TYR . . . -93.6 88.57 1.24 Allowed Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.1 m -135.15 166.19 23.65 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.56 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 1.9 m -98.82 144.0 28.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.78 0.324 . . . . 0.0 110.17 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.407 HD12 HG23 ' A' ' 20' ' ' ILE . 17.3 mm -96.73 120.95 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.648 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -114.14 136.59 52.77 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.544 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 59.76 12.18 2.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.202 0.525 . . . . 0.0 110.144 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.4 15.33 81.58 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -92.57 152.76 19.43 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.622 0.249 . . . . 0.0 110.348 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.2 mt -76.84 124.05 27.14 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.24 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 6.9 m0 -111.35 143.12 42.65 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.318 0.58 . . . . 0.0 110.508 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -92.58 151.08 20.33 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.499 ' H ' ' HA ' ' A' ' 15' ' ' ARG . 61.5 t80 -80.04 105.07 11.04 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.536 0.684 . . . . 0.0 109.579 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.621 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 5.4 t -94.35 130.03 40.82 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.036 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.573 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 6.9 t . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.404 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' CYS . . . . . 0.578 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 24.8 p . . . . . 0 N--CA 1.462 0.134 0 CA-C-O 120.698 0.285 . . . . 0.0 110.282 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.484 ' CD2' ' O ' ' A' ' 3' ' ' TYR . 15.3 p90 -148.0 69.17 1.11 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.083 0.468 . . . . 0.0 110.481 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 2.1 m -153.19 172.89 16.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.845 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ARG . . . . . 0.426 ' C ' ' CD1' ' A' ' 6' ' ' ILE . 0.6 OUTLIER -101.9 131.56 48.19 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 177.463 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.66 ' O ' ' N ' ' A' ' 8' ' ' ALA . 4.1 mp -145.52 131.74 9.67 Favored Pre-proline 0 C--N 1.304 -1.379 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -47.79 87.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.302 -1.902 0 N-CA-C 109.442 -1.022 . . . . 0.0 109.442 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.66 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -167.76 -160.9 0.36 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.239 -176.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 28.4 p -54.63 70.46 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.444 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.597 ' N ' ' O ' ' A' ' 8' ' ' ALA . 47.2 mt -68.23 -43.06 84.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.711 0.291 . . . . 0.0 110.446 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.57 171.9 4.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.697 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.98 -15.37 63.56 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.629 -0.989 . . . . 0.0 110.629 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 51.0 tp10 -157.67 147.17 20.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.814 0.34 . . . . 0.0 110.291 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . 0.401 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 90.9 mtm-85 -103.41 169.19 8.69 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.504 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -68.51 134.02 49.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.218 0.532 . . . . 0.0 110.985 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' TYR . . . . . 0.468 ' C ' ' H ' ' A' ' 18' ' ' THR . 73.2 m-85 -147.19 -106.87 0.09 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.258 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.27 45.7 0.98 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.468 ' H ' ' C ' ' A' ' 16' ' ' TYR . 4.3 p -79.58 165.62 22.75 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 1.2 p -99.18 149.59 22.91 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.429 HD13 HG22 ' A' ' 20' ' ' ILE . 19.6 mm -80.4 122.11 35.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.267 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . 0.424 ' C ' ' H ' ' A' ' 23' ' ' GLY . 27.4 m-85 -147.99 145.22 28.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.241 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 52.33 12.75 0.24 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.717 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.424 ' H ' ' C ' ' A' ' 21' ' ' TYR . . . 75.59 20.11 78.67 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -136.32 152.26 50.48 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.756 0.312 . . . . 0.0 110.616 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 59.7 mt -82.36 130.51 35.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.117 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 40.8 m0 -88.97 132.86 34.53 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.57 141.23 48.68 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -79.47 104.42 10.06 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.506 ' O ' ' SG ' ' A' ' 30' ' ' CYS . 44.8 t -94.47 134.6 36.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.977 -179.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.578 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 1.3 m . . . . . 0 C--O 1.221 -0.406 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.977 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.566 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 7.4 m -100.86 140.93 34.46 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.187 0.517 . . . . 0.0 110.461 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -92.63 -168.14 1.9 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.307 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.443 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 0.7 OUTLIER -85.41 -174.67 5.32 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.139 -179.461 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -94.28 112.27 24.05 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-O 121.246 0.546 . . . . 0.0 109.829 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.65 ' O ' ' N ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -136.67 139.33 28.87 Favored Pre-proline 0 N--CA 1.439 -0.993 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.299 179.079 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -46.04 72.65 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.685 2.257 . . . . 0.0 112.685 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.65 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -143.33 -163.31 1.62 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.44 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.513 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 29.9 p -58.63 69.81 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.609 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.586 ' N ' ' O ' ' A' ' 8' ' ' ALA . 86.6 mt -77.75 -21.12 13.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.3 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.445 ' O ' ' O ' ' A' ' 10' ' ' ILE . . . -54.01 -164.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.608 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.8 -59.44 2.58 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.504 ' OE1' ' N ' ' A' ' 13' ' ' GLU . 58.0 mp0 -143.76 149.62 37.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.024 0.44 . . . . 0.0 110.562 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -127.35 116.56 20.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.079 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.518 ' NE ' ' CH2' ' A' ' 26' ' ' TRP . 14.3 tpt180 -78.61 137.85 38.05 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.259 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -84.84 -40.66 16.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.682 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.91 155.22 52.72 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.3 p -126.82 142.28 51.59 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.658 0.266 . . . . 0.0 110.373 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.518 ' SG ' ' O ' ' A' ' 19' ' ' CYS . 12.9 p -102.46 119.23 38.47 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.217 0.532 . . . . 0.0 110.394 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.4 mm -90.23 96.8 6.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.156 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -146.89 106.09 3.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.107 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 40.2 tp60 63.6 14.29 7.98 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.051 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.23 33.69 19.54 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.494 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 96.1 mtt-85 -131.06 121.06 24.33 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.176 0.512 . . . . 0.0 110.574 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.0 mt -87.38 167.1 14.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.41 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.605 ' O ' ' CG ' ' A' ' 26' ' ' TRP . 1.2 p-90 -113.73 109.94 19.37 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.572 0.701 . . . . 0.0 111.268 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -95.67 159.69 14.86 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -75.31 102.13 4.97 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.098 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.513 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 7.9 t -122.42 122.8 39.84 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.991 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.566 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 44.4 m . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 118.112 -0.947 . . . . 0.0 110.372 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.575 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 20.6 p -157.07 151.29 25.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.538 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.48 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 7.9 p90 -139.45 66.18 1.41 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.196 0.522 . . . . 0.0 111.15 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -154.49 174.53 14.79 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.396 177.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 70.9 ttp85 -99.43 114.74 27.85 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 121.67 0.748 . . . . 0.0 109.161 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.656 ' O ' ' N ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER -137.19 133.11 18.26 Favored Pre-proline 0 C--N 1.305 -1.332 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 -179.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -47.19 85.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.302 -1.881 0 CA-C-N 119.725 0.938 . . . . 0.0 110.691 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.656 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -150.08 -164.83 2.11 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.491 -178.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 29.1 p -56.66 68.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.354 0.409 . . . . 0.0 111.162 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.598 ' N ' ' O ' ' A' ' 8' ' ' ALA . 4.9 mm -69.6 -25.44 28.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.753 0.311 . . . . 0.0 110.393 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.72 171.54 13.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.501 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.03 -17.79 58.61 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.548 ' OE2' ' CG ' ' A' ' 28' ' ' PHE . 72.6 tt0 -161.0 160.79 31.1 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 83.0 mmt-85 -103.39 157.26 17.15 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.133 0.492 . . . . 0.0 111.095 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -84.04 140.24 31.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.85 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.542 ' CD2' ' N ' ' A' ' 17' ' ' GLY . 84.8 t80 -146.65 -95.33 0.09 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.621 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.542 ' N ' ' CD2' ' A' ' 16' ' ' TYR . . . -60.56 77.04 0.01 OUTLIER Glycine 0 CA--C 1.522 0.499 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.537 ' N ' ' O ' ' A' ' 16' ' ' TYR . 60.1 p -79.9 164.08 23.82 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.894 -0.323 . . . . 0.0 111.324 -178.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.44 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 14.1 p -118.71 126.18 51.32 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.207 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.414 ' C ' ' CD1' ' A' ' 21' ' ' TYR . 5.4 mp -86.62 97.71 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.418 ' C ' ' N ' ' A' ' 23' ' ' GLY . 67.6 m-85 -146.35 143.82 29.36 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.438 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 50.17 15.61 0.2 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.8 0.333 . . . . 0.0 110.586 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.418 ' N ' ' C ' ' A' ' 21' ' ' TYR . . . 76.13 25.67 65.89 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -128.26 140.95 51.61 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.986 0.422 . . . . 0.0 110.944 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.574 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 2.2 mm? -89.62 157.85 17.86 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.529 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.541 ' CE3' ' O ' ' A' ' 17' ' ' GLY . 1.7 t90 -102.53 114.26 28.32 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.513 ' O ' ' CD1' ' A' ' 26' ' ' TRP . . . -89.42 152.69 21.35 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 177.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.548 ' CG ' ' OE2' ' A' ' 13' ' ' GLU . 0.8 OUTLIER -75.88 102.65 5.62 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 118.685 -1.206 . . . . 0.0 108.718 -178.547 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.44 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 12.9 t -108.0 153.83 22.52 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.318 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.575 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 2.6 m . . . . . 0 C--O 1.219 -0.507 0 CA-C-O 117.843 -1.075 . . . . 0.0 110.425 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.61 ' SG ' ' CE2' ' A' ' 28' ' ' PHE . 10.7 t -100.48 124.52 46.12 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.769 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.531 ' CD2' ' O ' ' A' ' 4' ' ' CYS . 56.8 t80 -102.99 151.5 22.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.346 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.568 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 2.7 m -88.17 154.08 20.73 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.43 ' HG3' ' H ' ' A' ' 6' ' ' ILE . 3.5 tpt180 -138.06 174.17 10.85 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 122.029 0.919 . . . . 0.0 111.99 -178.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.628 ' O ' ' N ' ' A' ' 8' ' ' ALA . 1.9 pt -99.73 162.14 22.11 Favored Pre-proline 0 N--CA 1.44 -0.954 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 177.077 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -47.86 76.27 0.01 OUTLIER 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 122.113 1.875 . . . . 0.0 113.813 -177.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.628 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -175.02 110.36 0.12 Allowed 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.16 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.552 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 55.8 m -70.46 70.3 0.42 Allowed 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.534 ' N ' ' O ' ' A' ' 8' ' ' ALA . 66.2 mt -66.28 -42.82 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-N 114.154 -1.384 . . . . 0.0 110.166 -178.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.22 -39.36 17.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.54 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.73 78.76 0.85 Allowed Glycine 0 CA--C 1.529 0.921 0 N-CA-C 111.815 -0.514 . . . . 0.0 111.815 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.516 ' O ' ' SG ' ' A' ' 9' ' ' CYS . 2.5 mm-40 -162.18 -179.18 6.86 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.987 0.422 . . . . 0.0 110.098 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -103.99 136.41 43.69 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.751 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.7 ptt-85 -75.49 132.08 40.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.445 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.423 ' H ' ' HB3' ' A' ' 28' ' ' PHE . 29.8 m-85 -148.55 -103.29 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.09 65.79 1.22 Allowed Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.386 -1.085 . . . . 0.0 110.386 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 26' ' ' TRP . 8.9 t -79.43 163.94 24.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.963 0.411 . . . . 0.0 110.746 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.568 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 2.3 m -101.4 154.07 19.12 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.786 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.6 mm -96.0 116.29 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 120.957 0.408 . . . . 0.0 110.577 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.411 ' C ' ' H ' ' A' ' 23' ' ' GLY . 43.1 m-85 -121.98 133.23 54.82 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.27 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 52.32 13.74 0.31 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.728 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.411 ' H ' ' C ' ' A' ' 21' ' ' TYR . . . 81.79 4.44 90.33 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -92.89 146.03 23.94 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.52 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 3.4 mm? -76.86 136.24 38.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.119 0.485 . . . . 0.0 110.342 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.435 ' O ' ' OG1' ' A' ' 18' ' ' THR . 3.8 m95 -111.59 143.89 41.72 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.597 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -90.42 118.53 29.97 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 175.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.61 ' CE2' ' SG ' ' A' ' 2' ' ' CYS . 26.0 t80 -76.99 100.03 5.49 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.552 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 1.3 m -130.13 126.28 37.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.46 -1.245 . . . . 0.0 109.43 -178.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.588 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 69.1 m . . . . . 0 C--O 1.218 -0.57 0 CA-C-O 118.101 -0.952 . . . . 0.0 111.556 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.581 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 16.7 p -152.85 158.7 42.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.303 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.503 ' O ' ' CD2' ' A' ' 3' ' ' TYR . 18.8 p90 -139.61 68.63 1.37 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.485 0.659 . . . . 0.0 110.773 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.478 ' C ' ' CD1' ' A' ' 26' ' ' TRP . 0.8 OUTLIER -151.28 179.14 8.57 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.303 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.474 HH11 ' CB ' ' A' ' 27' ' ' ALA . 57.7 ttt85 -95.59 122.36 38.26 Favored 'General case' 0 CA--C 1.489 -1.396 0 CA-C-O 122.485 1.136 . . . . 0.0 109.672 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.69 ' C ' ' H ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -104.37 158.24 32.36 Favored Pre-proline 0 N--CA 1.416 -2.174 0 N-CA-C 102.58 -3.119 . . . . 0.0 102.58 176.75 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -61.82 24.66 0.05 OUTLIER 'Trans proline' 0 C--N 1.274 -3.346 0 C-N-CA 121.08 1.187 . . . . 0.0 111.985 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.69 ' H ' ' C ' ' A' ' 6' ' ' ILE . . . -155.27 108.91 2.83 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.544 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.441 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 1.0 OUTLIER -62.85 99.29 0.15 Allowed 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 117.581 -1.648 . . . . 0.0 106.827 178.12 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.421 ' N ' ' O ' ' A' ' 8' ' ' ALA . 96.3 mt -65.08 -43.46 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.317 -176.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.52 -22.12 51.65 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.346 -0.541 . . . . 0.0 111.147 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.71 30.48 76.35 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.551 ' OE1' ' CD1' ' A' ' 28' ' ' PHE . 83.1 mt-10 -100.79 -175.82 3.0 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.367 0.603 . . . . 0.0 111.358 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 85.8 mtp180 -101.03 143.5 31.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.765 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.495 ' H ' ' HD2' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -68.41 142.13 55.49 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.297 -179.352 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.537 ' CD2' ' N ' ' A' ' 17' ' ' GLY . 70.6 t80 -148.63 -99.15 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.886 0.374 . . . . 0.0 110.868 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.537 ' N ' ' CD2' ' A' ' 16' ' ' TYR . . . -79.43 68.51 3.15 Favored Glycine 0 CA--C 1.52 0.347 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.4 ' CG2' ' O ' ' A' ' 26' ' ' TRP . 6.3 p -80.49 165.33 22.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.091 0.472 . . . . 0.0 111.991 -178.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.417 ' H ' ' HB3' ' A' ' 26' ' ' TRP . 9.4 p -100.03 139.22 36.01 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.126 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 21.0 mm -78.39 122.85 34.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.998 0.428 . . . . 0.0 110.316 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.445 ' C ' ' H ' ' A' ' 23' ' ' GLY . 86.5 t80 -153.53 128.69 9.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.582 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 43.2 tp60 51.87 12.39 0.19 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.07 0.462 . . . . 0.0 110.213 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.445 ' H ' ' C ' ' A' ' 21' ' ' TYR . . . 86.39 -2.26 87.44 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -98.26 135.1 40.37 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 76.1 mt -80.92 138.33 36.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.157 0.503 . . . . 0.0 110.562 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.701 ' CD1' ' O ' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -77.78 111.72 13.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.861 179.146 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.701 ' O ' ' CD1' ' A' ' 26' ' ' TRP . . . -66.39 149.14 50.84 Favored 'General case' 0 C--O 1.218 -0.605 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.037 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.551 ' CD1' ' OE1' ' A' ' 13' ' ' GLU . 3.0 t80 -73.24 104.07 4.16 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 118.691 -1.204 . . . . 0.0 110.027 -178.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.441 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 12.7 m -122.29 164.85 17.18 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 113.382 -1.735 . . . . 0.0 109.292 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.581 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 5.2 m . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.01 -0.995 . . . . 0.0 111.027 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.553 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 8.0 t -101.81 176.45 5.21 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.315 0.579 . . . . 0.0 110.988 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.552 ' N ' ' SG ' ' A' ' 30' ' ' CYS . 58.6 m-85 -131.45 151.58 51.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.248 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.584 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 56.7 m -87.78 -175.13 5.04 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.839 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 51.4 ttt85 -92.11 114.72 27.33 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 122.743 1.259 . . . . 0.0 111.065 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.6 ' O ' ' N ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -139.44 129.95 14.49 Favored Pre-proline 0 N--CA 1.426 -1.645 0 N-CA-C 103.268 -2.864 . . . . 0.0 103.268 176.097 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -47.4 90.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.295 -2.257 0 CA-C-N 121.002 1.394 . . . . 0.0 110.893 -177.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.6 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -146.85 -161.44 1.33 Allowed 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.792 -177.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.57 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 28.2 p -57.52 76.76 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.356 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.575 ' N ' ' O ' ' A' ' 8' ' ' ALA . 52.5 mt -68.66 -18.54 23.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.59 -164.67 1.16 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.028 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.06 -102.96 2.44 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -100.78 167.07 10.54 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 85.1 mtm-85 -101.3 162.97 12.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.09 0.472 . . . . 0.0 110.921 -179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -67.29 134.56 51.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.874 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.48 ' N ' ' SG ' ' A' ' 2' ' ' CYS . 88.0 t80 -85.74 -15.56 41.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.292 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 178.03 110.02 0.26 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.489 ' OG1' ' CD1' ' A' ' 26' ' ' TRP . 0.0 OUTLIER -79.25 144.22 34.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.819 0.343 . . . . 0.0 110.63 -179.878 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.584 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 25.8 p -133.29 118.43 18.53 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.103 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.5 mt -87.98 139.15 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 CA-C-O 121.194 0.521 . . . . 0.0 110.877 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -149.47 115.15 5.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.493 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 50.56 33.77 8.52 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.699 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.69 36.03 7.03 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.784 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 60.7 ttm-85 -90.41 132.38 35.65 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.238 0.542 . . . . 0.0 110.719 -179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.526 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 3.6 mm? -95.64 163.15 13.32 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.538 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.489 ' CD1' ' OG1' ' A' ' 18' ' ' THR . 61.8 p-90 -122.16 138.91 54.3 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 122.074 0.94 . . . . 0.0 110.874 178.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -115.58 160.41 20.02 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 113.695 -1.593 . . . . 0.0 107.974 178.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.464 ' O ' ' O ' ' A' ' 10' ' ' ILE . 85.7 m-85 -75.22 100.76 4.42 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 178.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.57 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 8.6 t -139.01 -173.25 3.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.173 -176.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.553 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 2.7 m . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.897 -1.049 . . . . 0.0 110.626 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 5.6 p -151.95 136.72 17.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.247 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.411 ' C ' ' CD1' ' A' ' 26' ' ' TRP . 42.1 m-85 -125.37 66.91 1.14 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.89 0.376 . . . . 0.0 110.641 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.611 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -153.37 173.68 15.33 Favored 'General case' 0 C--O 1.214 -0.764 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.691 HH11 ' NH2' ' A' ' 15' ' ' ARG . 62.4 ttp180 -100.09 111.47 23.76 Favored 'General case' 0 CA--C 1.479 -1.782 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.561 ' C ' ' H ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -108.39 158.78 32.95 Favored Pre-proline 0 C--N 1.299 -1.605 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 178.948 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -48.9 -6.18 0.05 OUTLIER 'Trans proline' 0 C--N 1.28 -3.069 0 C-N-CA 120.76 0.974 . . . . 0.0 112.193 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.561 ' H ' ' C ' ' A' ' 6' ' ' ILE . . . -127.41 105.79 8.76 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.299 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.621 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 1.7 p 155.25 5.19 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.1 mm -66.73 -42.51 89.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 C-N-CA 119.624 -0.831 . . . . 0.0 109.112 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -101.76 154.41 18.93 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.881 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.83 6.2 85.54 Favored Glycine 0 N--CA 1.466 0.649 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.55 ' CG ' ' O ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER -163.22 -176.8 5.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.815 0.34 . . . . 0.0 110.588 -179.002 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -131.82 152.67 50.83 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.682 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.691 ' NH2' HH11 ' A' ' 5' ' ' ARG . 42.0 ttm180 -86.21 100.43 12.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.808 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -102.08 -101.7 0.27 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.88 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.533 ' O ' ' CE3' ' A' ' 26' ' ' TRP . . . -59.22 112.32 4.12 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.414 ' HA ' ' H ' ' A' ' 26' ' ' TRP . 0.1 OUTLIER -102.44 123.8 46.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.951 0.405 . . . . 0.0 110.419 -179.488 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.497 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 7.3 p -101.72 131.69 47.85 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.029 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 15.3 mm -84.65 113.82 23.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 C-N-CA 120.224 -0.59 . . . . 0.0 109.789 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -149.13 114.88 5.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.172 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 49.1 21.42 0.49 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.49 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.83 29.53 26.02 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' A' ' 19' ' ' CYS . 99.7 mtt180 -124.88 122.24 36.82 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.819 0.342 . . . . 0.0 110.932 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.4 mt -80.27 162.56 24.54 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.736 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.533 ' CE3' ' O ' ' A' ' 17' ' ' GLY . 1.7 t90 -97.02 116.5 29.33 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.026 0.441 . . . . 0.0 110.022 178.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.446 ' O ' ' CD1' ' A' ' 26' ' ' TRP . . . -96.53 151.73 19.3 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.427 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 47.0 t80 -75.94 101.07 5.05 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 118.736 -1.186 . . . . 0.0 108.612 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.621 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 61.4 m -96.16 144.12 26.68 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.869 -178.135 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 2.6 m . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.399 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.652 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.572 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 4.9 m -100.04 142.79 31.04 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-O 121.622 0.725 . . . . 0.0 110.67 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -93.41 -171.49 2.65 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.566 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 5.8 t -87.96 -176.92 5.63 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' ' 25' ' ' LEU . 72.5 ttt180 -94.89 111.99 23.74 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 122.333 1.063 . . . . 0.0 109.894 -178.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.558 ' O ' ' N ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -126.94 131.47 23.89 Favored Pre-proline 0 C--N 1.304 -1.394 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 177.383 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -46.93 95.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.301 -1.941 0 CA-C-N 120.894 1.355 . . . . 0.0 110.086 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.635 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -153.58 -164.35 1.87 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.008 -177.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.555 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 26.9 p -54.37 75.97 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.635 ' N ' ' O ' ' A' ' 8' ' ' ALA . 8.7 tp -69.77 -39.71 78.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.35 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.16 172.14 0.87 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.477 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.95 -24.34 28.98 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 -162.3 153.97 18.46 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 90.9 mtm-85 -103.25 155.83 18.16 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.018 0.437 . . . . 0.0 110.7 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 53.3 ptt85 -87.63 140.56 29.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.937 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -108.1 -65.15 1.14 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.092 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 26' ' ' TRP . . . -98.57 166.28 21.67 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.69 124.52 22.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.918 0.39 . . . . 0.0 110.663 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.566 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 14.1 p -101.09 130.04 47.07 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.432 HD13 HG22 ' A' ' 20' ' ' ILE . 11.0 mm -95.33 116.32 36.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.016 0.436 . . . . 0.0 109.943 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.408 ' C ' ' H ' ' A' ' 23' ' ' GLY . 90.7 t80 -166.45 126.87 1.65 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.434 -179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 55.69 12.54 0.84 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.176 0.512 . . . . 0.0 109.858 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.408 ' H ' ' C ' ' A' ' 21' ' ' TYR . . . 83.89 26.09 42.89 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.648 -0.581 . . . . 0.0 111.648 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.466 ' O ' ' O ' ' A' ' 19' ' ' CYS . 90.4 mtm180 -118.14 137.25 53.09 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.729 0.3 . . . . 0.0 110.634 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.573 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 0.7 OUTLIER -96.87 164.72 12.43 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.775 -179.292 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.478 ' CZ2' ' O ' ' A' ' 2' ' ' CYS . 25.8 t-105 -101.39 109.23 21.04 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 121.105 0.478 . . . . 0.0 111.167 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -114.83 147.72 39.47 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 176.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.404 ' CD2' ' SG ' ' A' ' 2' ' ' CYS . 9.3 m-85 -78.63 101.12 7.3 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.555 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 8.4 t -117.83 123.48 46.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.751 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.572 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 0.9 OUTLIER . . . . . 0 C--O 1.221 -0.437 0 CA-C-O 117.809 -1.091 . . . . 0.0 109.802 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.58 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 93.1 m -101.2 128.12 47.45 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.159 0.504 . . . . 0.0 110.943 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -92.55 152.59 19.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.768 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 3.5 m -88.24 151.2 22.82 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.425 ' O ' ' N ' ' A' ' 27' ' ' ALA . 2.4 tpt180 -130.69 173.44 10.91 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 122.149 0.976 . . . . 0.0 111.363 -178.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.648 ' O ' ' N ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER -100.74 164.37 16.29 Favored Pre-proline 0 C--N 1.312 -1.03 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 177.059 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -46.2 75.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.301 -1.935 0 C-N-CA 122.467 2.111 . . . . 0.0 114.057 -176.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.648 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -174.91 109.16 0.11 Allowed 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 113.551 -1.659 . . . . 0.0 108.61 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.556 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 5.1 m -72.0 68.33 0.68 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.461 ' N ' ' O ' ' A' ' 8' ' ' ALA . 57.6 mt -68.88 -22.74 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-N 113.991 -1.459 . . . . 0.0 110.743 -178.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.45 -43.69 14.38 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.236 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.5 41.67 1.12 Allowed Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.542 ' OE1' ' SG ' ' A' ' 30' ' ' CYS . 12.5 pt-20 -146.78 -173.91 4.34 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 81.5 mtm-85 -101.04 149.48 23.89 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.003 0.43 . . . . 0.0 112.137 -178.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 47.0 ptt85 -91.09 128.66 37.0 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.859 179.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 91.9 t80 -147.22 -72.48 0.22 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.18 81.42 1.59 Allowed Glycine 0 CA--C 1.524 0.609 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.8 t -110.03 158.44 18.27 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.183 0.516 . . . . 0.0 110.647 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 0.7 OUTLIER -100.71 148.91 24.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.26 179.673 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.6 mm -94.27 119.0 41.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.019 0.437 . . . . 0.0 110.403 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -130.65 142.01 50.43 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.871 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 56.58 12.29 1.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.604 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.27 -1.16 71.67 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -93.09 149.99 20.84 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.641 0.258 . . . . 0.0 110.52 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 10.7 mp -77.48 139.23 39.59 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.986 0.422 . . . . 0.0 110.315 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -109.63 142.24 41.04 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.668 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 5' ' ' ARG . . . -87.22 114.36 23.77 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 175.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -75.82 99.87 4.58 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 118.062 -1.455 . . . . 0.0 107.19 -179.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.556 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 1.2 m -141.35 123.62 15.68 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 113.515 -1.675 . . . . 0.0 108.932 -178.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.58 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 46.0 m . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 117.895 -1.05 . . . . 0.0 111.605 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.573 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 70.7 m -100.87 131.67 46.64 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.845 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.478 ' CD2' ' O ' ' A' ' 4' ' ' CYS . 58.7 t80 -92.4 152.18 19.86 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.56 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 33.6 m -88.48 148.52 24.13 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.823 0.344 . . . . 0.0 110.92 -178.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.421 ' HG3' ' H ' ' A' ' 6' ' ' ILE . 1.9 tpt180 -156.09 178.03 10.75 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.86 0.838 . . . . 0.0 111.041 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.662 ' O ' ' N ' ' A' ' 8' ' ' ALA . 0.7 OUTLIER -94.84 166.75 14.41 Favored Pre-proline 0 N--CA 1.439 -1.012 0 N-CA-C 103.318 -2.845 . . . . 0.0 103.318 177.216 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -50.86 54.88 0.02 OUTLIER 'Trans proline' 0 N--CA 1.507 2.317 0 C-N-CA 122.425 2.083 . . . . 0.0 115.88 -176.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.662 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -175.14 101.82 0.08 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.77 -0.196 . . . . 0.0 110.808 177.055 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.621 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 35.4 t 151.36 -8.24 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.547 ' C ' ' H ' ' A' ' 12' ' ' GLY . 8.3 mt -68.3 125.37 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 CA-C-N 114.277 -1.328 . . . . 0.0 109.585 -177.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.24 12.77 0.85 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.547 ' H ' ' C ' ' A' ' 10' ' ' ILE . . . 114.09 80.11 0.92 Allowed Glycine 0 CA--C 1.527 0.812 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.041 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -161.88 168.42 23.04 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 85.1 mmt-85 -103.78 158.82 16.13 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.962 0.411 . . . . 0.0 111.026 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.499 ' HA ' ' H ' ' A' ' 28' ' ' PHE . 33.2 ptt180 -70.71 127.65 33.38 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.492 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.503 ' CD2' ' N ' ' A' ' 17' ' ' GLY . 90.4 t80 -147.41 -91.16 0.09 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.574 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.503 ' N ' ' CD2' ' A' ' 16' ' ' TYR . . . -93.6 88.57 1.24 Allowed Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.1 m -135.15 166.19 23.65 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.56 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 1.9 m -98.82 144.0 28.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.78 0.324 . . . . 0.0 110.17 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.407 HD12 HG23 ' A' ' 20' ' ' ILE . 17.3 mm -96.73 120.95 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.648 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -114.14 136.59 52.77 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.544 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 59.76 12.18 2.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.202 0.525 . . . . 0.0 110.144 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.4 15.33 81.58 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 89.8 mtm180 -92.57 152.76 19.43 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.622 0.249 . . . . 0.0 110.348 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.2 mt -76.84 124.05 27.14 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.24 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 6.9 m0 -111.35 143.12 42.65 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.318 0.58 . . . . 0.0 110.508 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -92.58 151.08 20.33 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.499 ' H ' ' HA ' ' A' ' 15' ' ' ARG . 61.5 t80 -80.04 105.07 11.04 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.536 0.684 . . . . 0.0 109.579 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.621 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 5.4 t -94.35 130.03 40.82 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.036 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.573 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 6.9 t . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.404 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' CYS . . . . . 0.578 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 24.8 p -152.69 155.11 36.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.282 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.484 ' CD2' ' O ' ' A' ' 3' ' ' TYR . 15.3 p90 -148.0 69.17 1.11 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.083 0.468 . . . . 0.0 110.481 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 2.1 m -153.19 172.89 16.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.845 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ARG . . . . . 0.426 ' C ' ' CD1' ' A' ' 6' ' ' ILE . 0.6 OUTLIER -101.9 131.56 48.19 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 177.463 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.66 ' O ' ' N ' ' A' ' 8' ' ' ALA . 4.1 mp -145.52 131.74 9.67 Favored Pre-proline 0 C--N 1.304 -1.379 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -47.79 87.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.302 -1.902 0 N-CA-C 109.442 -1.022 . . . . 0.0 109.442 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.66 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -167.76 -160.9 0.36 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.239 -176.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 28.4 p -54.63 70.46 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.444 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.597 ' N ' ' O ' ' A' ' 8' ' ' ALA . 47.2 mt -68.23 -43.06 84.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.711 0.291 . . . . 0.0 110.446 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.57 171.9 4.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.697 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.98 -15.37 63.56 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.629 -0.989 . . . . 0.0 110.629 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 51.0 tp10 -157.67 147.17 20.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.814 0.34 . . . . 0.0 110.291 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.401 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 90.9 mtm-85 -103.41 169.19 8.69 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.504 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -68.51 134.02 49.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.218 0.532 . . . . 0.0 110.985 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' TYR . . . . . 0.468 ' C ' ' H ' ' A' ' 18' ' ' THR . 73.2 m-85 -147.19 -106.87 0.09 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.258 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.27 45.7 0.98 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.468 ' H ' ' C ' ' A' ' 16' ' ' TYR . 4.3 p -79.58 165.62 22.75 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 1.2 p -99.18 149.59 22.91 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.429 HD13 HG22 ' A' ' 20' ' ' ILE . 19.6 mm -80.4 122.11 35.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.267 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . 0.424 ' C ' ' H ' ' A' ' 23' ' ' GLY . 27.4 m-85 -147.99 145.22 28.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.241 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 52.33 12.75 0.24 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.717 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.424 ' H ' ' C ' ' A' ' 21' ' ' TYR . . . 75.59 20.11 78.67 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -136.32 152.26 50.48 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.756 0.312 . . . . 0.0 110.616 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 59.7 mt -82.36 130.51 35.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.117 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 40.8 m0 -88.97 132.86 34.53 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.57 141.23 48.68 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -79.47 104.42 10.06 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.506 ' O ' ' SG ' ' A' ' 30' ' ' CYS . 44.8 t -94.47 134.6 36.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.977 -179.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.578 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 1.3 m . . . . . 0 C--O 1.221 -0.406 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.977 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.559 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 7.4 m . . . . . 0 N--CA 1.469 0.484 0 CA-C-O 121.187 0.517 . . . . 0.0 110.461 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -92.63 -168.14 1.9 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.307 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.497 ' O ' HD13 ' A' ' 6' ' ' ILE . 0.7 OUTLIER -85.41 -174.67 5.32 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.139 -179.461 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -94.28 112.27 24.05 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-O 121.246 0.546 . . . . 0.0 109.829 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.65 ' O ' ' N ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -136.67 139.33 28.87 Favored Pre-proline 0 N--CA 1.439 -0.993 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.299 179.079 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -46.04 72.65 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.685 2.257 . . . . 0.0 112.685 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.65 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -143.33 -163.31 1.62 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.44 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.51 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 29.9 p -58.63 69.81 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.609 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.586 ' N ' ' O ' ' A' ' 8' ' ' ALA . 86.6 mt -77.75 -21.12 13.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.3 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.445 ' O ' ' O ' ' A' ' 10' ' ' ILE . . . -54.01 -164.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.608 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.8 -59.44 2.58 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.504 ' OE1' ' N ' ' A' ' 13' ' ' GLU . 58.0 mp0 -143.76 149.62 37.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.024 0.44 . . . . 0.0 110.562 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -127.35 116.56 20.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.079 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.518 ' NE ' ' CH2' ' A' ' 26' ' ' TRP . 14.3 tpt180 -78.61 137.85 38.05 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.259 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -84.84 -40.66 16.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.682 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.91 155.22 52.72 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.3 p -126.82 142.28 51.59 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.658 0.266 . . . . 0.0 110.373 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.518 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 12.9 p -102.46 119.23 38.47 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.217 0.532 . . . . 0.0 110.394 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.4 mm -90.23 96.8 6.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.156 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -146.89 106.09 3.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.107 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 40.2 tp60 63.6 14.29 7.98 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.051 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.23 33.69 19.54 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.491 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 96.1 mtt-85 -131.06 121.06 24.33 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.176 0.512 . . . . 0.0 110.574 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.434 ' N ' HD23 ' A' ' 25' ' ' LEU . 4.0 mt -87.38 167.1 14.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.41 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.605 ' O ' ' CG ' ' A' ' 26' ' ' TRP . 1.2 p-90 -113.73 109.94 19.37 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.572 0.701 . . . . 0.0 111.268 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -95.67 159.69 14.86 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -75.31 102.13 4.97 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.098 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.482 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 7.9 t -122.42 122.8 39.84 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.991 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.559 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 44.4 m . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 118.112 -0.947 . . . . 0.0 110.372 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.575 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 20.6 p . . . . . 0 CA--C 1.52 -0.208 0 CA-C-O 120.681 0.277 . . . . 0.0 110.538 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.48 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 7.9 p90 -139.45 66.18 1.41 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.196 0.522 . . . . 0.0 111.15 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -154.49 174.53 14.79 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.396 177.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 70.9 ttp85 -99.43 114.74 27.85 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 121.67 0.748 . . . . 0.0 109.161 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.845 ' H ' HD12 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -137.19 133.11 18.26 Favored Pre-proline 0 C--N 1.305 -1.332 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 -179.896 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -47.19 85.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.302 -1.881 0 CA-C-N 119.725 0.938 . . . . 0.0 110.691 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.656 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -150.08 -164.83 2.11 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.491 -178.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 29.1 p -56.66 68.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.354 0.409 . . . . 0.0 111.162 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.598 ' N ' ' O ' ' A' ' 8' ' ' ALA . 4.9 mm -69.6 -25.44 28.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.753 0.311 . . . . 0.0 110.393 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.72 171.54 13.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.501 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.03 -17.79 58.61 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.548 ' OE2' ' CG ' ' A' ' 28' ' ' PHE . 72.6 tt0 -161.0 160.79 31.1 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 83.0 mmt-85 -103.39 157.26 17.15 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.133 0.492 . . . . 0.0 111.095 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.608 ' NH2' HG21 ' A' ' 18' ' ' THR . 9.3 ptm180 -84.04 140.24 31.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.85 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.616 ' O ' HG23 ' A' ' 18' ' ' THR . 84.8 t80 -146.65 -95.33 0.09 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.621 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.542 ' N ' ' CD2' ' A' ' 16' ' ' TYR . . . -60.56 77.04 0.01 OUTLIER Glycine 0 CA--C 1.522 0.499 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.616 HG23 ' O ' ' A' ' 16' ' ' TYR . 60.1 p -79.9 164.08 23.82 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.894 -0.323 . . . . 0.0 111.324 -178.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.44 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 14.1 p -118.71 126.18 51.32 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.207 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.453 ' H ' HD12 ' A' ' 20' ' ' ILE . 5.4 mp -86.62 97.71 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.418 ' C ' ' N ' ' A' ' 23' ' ' GLY . 67.6 m-85 -146.35 143.82 29.36 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.438 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 50.17 15.61 0.2 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.8 0.333 . . . . 0.0 110.586 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.418 ' N ' ' C ' ' A' ' 21' ' ' TYR . . . 76.13 25.67 65.89 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -128.26 140.95 51.61 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.986 0.422 . . . . 0.0 110.944 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.771 HD22 ' N ' ' A' ' 25' ' ' LEU . 2.2 mm? -89.62 157.85 17.86 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.529 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.541 ' CE3' ' O ' ' A' ' 17' ' ' GLY . 1.7 t90 -102.53 114.26 28.32 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.513 ' O ' ' CD1' ' A' ' 26' ' ' TRP . . . -89.42 152.69 21.35 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 177.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.548 ' CG ' ' OE2' ' A' ' 13' ' ' GLU . 0.8 OUTLIER -75.88 102.65 5.62 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 118.685 -1.206 . . . . 0.0 108.718 -178.547 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.44 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 12.9 t -108.0 153.83 22.52 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.318 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.575 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 2.6 m . . . . . 0 C--O 1.219 -0.507 0 CA-C-O 117.843 -1.075 . . . . 0.0 110.425 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 10.7 t . . . . . 0 CA--C 1.519 -0.247 0 CA-C-O 120.981 0.42 . . . . 0.0 110.769 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.531 ' CD2' ' O ' ' A' ' 4' ' ' CYS . 56.8 t80 -102.99 151.5 22.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.346 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.553 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 2.7 m -88.17 154.08 20.73 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.595 HH21 HG21 ' A' ' 10' ' ' ILE . 3.5 tpt180 -138.06 174.17 10.85 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 122.029 0.919 . . . . 0.0 111.99 -178.176 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.628 ' O ' ' N ' ' A' ' 8' ' ' ALA . 1.9 pt -99.73 162.14 22.11 Favored Pre-proline 0 N--CA 1.44 -0.954 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 177.077 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.499 ' HA ' ' HB2' ' A' ' 27' ' ' ALA . 93.0 Cg_exo -47.86 76.27 0.01 OUTLIER 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 122.113 1.875 . . . . 0.0 113.813 -177.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.628 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -175.02 110.36 0.12 Allowed 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.16 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.539 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 55.8 m -70.46 70.3 0.42 Allowed 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.595 HG21 HH21 ' A' ' 5' ' ' ARG . 66.2 mt -66.28 -42.82 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-N 114.154 -1.384 . . . . 0.0 110.166 -178.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.22 -39.36 17.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.54 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.73 78.76 0.85 Allowed Glycine 0 CA--C 1.529 0.921 0 N-CA-C 111.815 -0.514 . . . . 0.0 111.815 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.516 ' O ' ' SG ' ' A' ' 9' ' ' CYS . 2.5 mm-40 -162.18 -179.18 6.86 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.987 0.422 . . . . 0.0 110.098 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -103.99 136.41 43.69 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.751 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.418 ' H ' ' HG2' ' A' ' 15' ' ' ARG . 31.7 ptt-85 -75.49 132.08 40.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.445 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.473 ' H ' ' HB3' ' A' ' 28' ' ' PHE . 29.8 m-85 -148.55 -103.29 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.09 65.79 1.22 Allowed Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.386 -1.085 . . . . 0.0 110.386 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 26' ' ' TRP . 8.9 t -79.43 163.94 24.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.963 0.411 . . . . 0.0 110.746 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.553 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 2.3 m -101.4 154.07 19.12 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.786 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.6 mm -96.0 116.29 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 120.957 0.408 . . . . 0.0 110.577 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -121.98 133.23 54.82 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.27 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 52.32 13.74 0.31 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.728 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.79 4.44 90.33 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -92.89 146.03 23.94 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.561 HD22 ' N ' ' A' ' 25' ' ' LEU . 3.4 mm? -76.86 136.24 38.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.119 0.485 . . . . 0.0 110.342 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.435 ' O ' ' OG1' ' A' ' 18' ' ' THR . 3.8 m95 -111.59 143.89 41.72 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.597 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.499 ' HB2' ' HA ' ' A' ' 7' ' ' PRO . . . -90.42 118.53 29.97 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 175.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.473 ' HB3' ' H ' ' A' ' 16' ' ' TYR . 26.0 t80 -76.99 100.03 5.49 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.539 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 1.3 m -130.13 126.28 37.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.46 -1.245 . . . . 0.0 109.43 -178.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 69.1 m . . . . . 0 C--O 1.218 -0.57 0 CA-C-O 118.101 -0.952 . . . . 0.0 111.556 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.581 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 16.7 p . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.655 0.264 . . . . 0.0 110.303 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.503 ' O ' ' CD2' ' A' ' 3' ' ' TYR . 18.8 p90 -139.61 68.63 1.37 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.485 0.659 . . . . 0.0 110.773 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.478 ' C ' ' CD1' ' A' ' 26' ' ' TRP . 0.8 OUTLIER -151.28 179.14 8.57 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.303 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.487 HH11 ' CB ' ' A' ' 27' ' ' ALA . 57.7 ttt85 -95.59 122.36 38.26 Favored 'General case' 0 CA--C 1.489 -1.396 0 CA-C-O 122.485 1.136 . . . . 0.0 109.672 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.897 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -104.37 158.24 32.36 Favored Pre-proline 0 N--CA 1.416 -2.174 0 N-CA-C 102.58 -3.119 . . . . 0.0 102.58 176.75 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -61.82 24.66 0.05 OUTLIER 'Trans proline' 0 C--N 1.274 -3.346 0 C-N-CA 121.08 1.187 . . . . 0.0 111.985 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.665 ' H ' ' C ' ' A' ' 6' ' ' ILE . . . -155.27 108.91 2.83 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.544 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -62.85 99.29 0.15 Allowed 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 117.581 -1.648 . . . . 0.0 106.827 178.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.422 ' HB ' ' H ' ' A' ' 30' ' ' CYS . 96.3 mt -65.08 -43.46 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.317 -176.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.424 ' H ' ' HA ' ' A' ' 29' ' ' CYS . . . -77.52 -22.12 51.65 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.346 -0.541 . . . . 0.0 111.147 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.71 30.48 76.35 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.551 ' OE1' ' CD1' ' A' ' 28' ' ' PHE . 83.1 mt-10 -100.79 -175.82 3.0 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.367 0.603 . . . . 0.0 111.358 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 85.8 mtp180 -101.03 143.5 31.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.765 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.578 ' H ' ' HD2' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -68.41 142.13 55.49 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.297 -179.352 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.537 ' CD2' ' N ' ' A' ' 17' ' ' GLY . 70.6 t80 -148.63 -99.15 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.886 0.374 . . . . 0.0 110.868 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.537 ' N ' ' CD2' ' A' ' 16' ' ' TYR . . . -79.43 68.51 3.15 Favored Glycine 0 CA--C 1.52 0.347 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.442 HG22 ' O ' ' A' ' 26' ' ' TRP . 6.3 p -80.49 165.33 22.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.091 0.472 . . . . 0.0 111.991 -178.298 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.472 ' H ' ' HB3' ' A' ' 26' ' ' TRP . 9.4 p -100.03 139.22 36.01 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.126 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 21.0 mm -78.39 122.85 34.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.998 0.428 . . . . 0.0 110.316 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TYR . . . . . 0.424 ' C ' ' N ' ' A' ' 23' ' ' GLY . 86.5 t80 -153.53 128.69 9.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.582 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 43.2 tp60 51.87 12.39 0.19 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.07 0.462 . . . . 0.0 110.213 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.424 ' N ' ' C ' ' A' ' 21' ' ' TYR . . . 86.39 -2.26 87.44 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -98.26 135.1 40.37 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 76.1 mt -80.92 138.33 36.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.157 0.503 . . . . 0.0 110.562 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.701 ' CD1' ' O ' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -77.78 111.72 13.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.861 179.146 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.701 ' O ' ' CD1' ' A' ' 26' ' ' TRP . . . -66.39 149.14 50.84 Favored 'General case' 0 C--O 1.218 -0.605 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.037 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.551 ' CD1' ' OE1' ' A' ' 13' ' ' GLU . 3.0 t80 -73.24 104.07 4.16 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 118.691 -1.204 . . . . 0.0 110.027 -178.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.424 ' HA ' ' H ' ' A' ' 11' ' ' ALA . 12.7 m -122.29 164.85 17.18 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 113.382 -1.735 . . . . 0.0 109.292 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.581 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 5.2 m . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.01 -0.995 . . . . 0.0 111.027 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.48 ' SG ' ' N ' ' A' ' 16' ' ' TYR . 8.0 t . . . . . 0 CA--C 1.512 -0.486 0 CA-C-O 121.315 0.579 . . . . 0.0 110.988 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.552 ' N ' ' SG ' ' A' ' 30' ' ' CYS . 58.6 m-85 -131.45 151.58 51.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.248 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.584 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 56.7 m -87.78 -175.13 5.04 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.839 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 51.4 ttt85 -92.11 114.72 27.33 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 122.743 1.259 . . . . 0.0 111.065 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.6 ' O ' ' N ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -139.44 129.95 14.49 Favored Pre-proline 0 N--CA 1.426 -1.645 0 N-CA-C 103.268 -2.864 . . . . 0.0 103.268 176.097 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -47.4 90.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.295 -2.257 0 CA-C-N 121.002 1.394 . . . . 0.0 110.893 -177.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.6 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -146.85 -161.44 1.33 Allowed 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.792 -177.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.57 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 28.2 p -57.52 76.76 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.356 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.575 ' N ' ' O ' ' A' ' 8' ' ' ALA . 52.5 mt -68.66 -18.54 23.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.59 -164.67 1.16 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.028 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.06 -102.96 2.44 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.405 ' HG2' ' N ' ' A' ' 14' ' ' ARG . 77.6 tt0 -100.78 167.07 10.54 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.405 ' N ' ' HG2' ' A' ' 13' ' ' GLU . 85.1 mtm-85 -101.3 162.97 12.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.09 0.472 . . . . 0.0 110.921 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -67.29 134.56 51.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.874 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.48 ' N ' ' SG ' ' A' ' 2' ' ' CYS . 88.0 t80 -85.74 -15.56 41.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.292 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 178.03 110.02 0.26 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.459 HG22 ' H ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -79.25 144.22 34.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.819 0.343 . . . . 0.0 110.63 -179.878 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.584 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 25.8 p -133.29 118.43 18.53 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.103 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.5 mt -87.98 139.15 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 CA-C-O 121.194 0.521 . . . . 0.0 110.877 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -149.47 115.15 5.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.493 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 50.56 33.77 8.52 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.699 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.69 36.03 7.03 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.784 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.422 ' C ' HD22 ' A' ' 25' ' ' LEU . 60.7 ttm-85 -90.41 132.38 35.65 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.238 0.542 . . . . 0.0 110.719 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.595 ' N ' HD22 ' A' ' 25' ' ' LEU . 3.6 mm? -95.64 163.15 13.32 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.538 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.413 ' CD1' ' OG1' ' A' ' 18' ' ' THR . 61.8 p-90 -122.16 138.91 54.3 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 122.074 0.94 . . . . 0.0 110.874 178.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -115.58 160.41 20.02 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 113.695 -1.593 . . . . 0.0 107.974 178.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.464 ' O ' ' O ' ' A' ' 10' ' ' ILE . 85.7 m-85 -75.22 100.76 4.42 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 178.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.57 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 8.6 t -139.01 -173.25 3.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.173 -176.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.552 ' SG ' ' N ' ' A' ' 3' ' ' TYR . 2.7 m . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.897 -1.049 . . . . 0.0 110.626 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 5.6 p . . . . . 0 CA--C 1.522 -0.134 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.411 ' C ' ' CD1' ' A' ' 26' ' ' TRP . 42.1 m-85 -125.37 66.91 1.14 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.89 0.376 . . . . 0.0 110.641 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.557 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -153.37 173.68 15.33 Favored 'General case' 0 C--O 1.214 -0.764 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.983 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.707 HH11 ' NH2' ' A' ' 15' ' ' ARG . 62.4 ttp180 -100.09 111.47 23.76 Favored 'General case' 0 CA--C 1.479 -1.782 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.552 ' O ' ' N ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -108.39 158.78 32.95 Favored Pre-proline 0 C--N 1.299 -1.605 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 178.948 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -48.9 -6.18 0.05 OUTLIER 'Trans proline' 0 C--N 1.28 -3.069 0 C-N-CA 120.76 0.974 . . . . 0.0 112.193 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -127.41 105.79 8.76 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.299 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.621 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 1.7 p 155.25 5.19 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.1 mm -66.73 -42.51 89.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 C-N-CA 119.624 -0.831 . . . . 0.0 109.112 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -101.76 154.41 18.93 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.881 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.83 6.2 85.54 Favored Glycine 0 N--CA 1.466 0.649 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.55 ' CG ' ' O ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER -163.22 -176.8 5.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.815 0.34 . . . . 0.0 110.588 -179.002 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -131.82 152.67 50.83 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.682 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.707 ' NH2' HH11 ' A' ' 5' ' ' ARG . 42.0 ttm180 -86.21 100.43 12.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.808 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -102.08 -101.7 0.27 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.88 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.533 ' O ' ' CE3' ' A' ' 26' ' ' TRP . . . -59.22 112.32 4.12 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.477 ' HA ' ' H ' ' A' ' 26' ' ' TRP . 0.1 OUTLIER -102.44 123.8 46.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.951 0.405 . . . . 0.0 110.419 -179.488 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.497 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 7.3 p -101.72 131.69 47.85 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.029 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 15.3 mm -84.65 113.82 23.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 C-N-CA 120.224 -0.59 . . . . 0.0 109.789 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -149.13 114.88 5.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.172 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 49.1 21.42 0.49 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.49 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.83 29.53 26.02 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' A' ' 19' ' ' CYS . 99.7 mtt180 -124.88 122.24 36.82 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.819 0.342 . . . . 0.0 110.932 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.4 mt -80.27 162.56 24.54 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.736 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.533 ' CE3' ' O ' ' A' ' 17' ' ' GLY . 1.7 t90 -97.02 116.5 29.33 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.026 0.441 . . . . 0.0 110.022 178.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.446 ' O ' ' CD1' ' A' ' 26' ' ' TRP . . . -96.53 151.73 19.3 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.427 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 47.0 t80 -75.94 101.07 5.05 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 118.736 -1.186 . . . . 0.0 108.612 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.621 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 61.4 m -96.16 144.12 26.68 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.869 -178.135 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 2.6 m . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.399 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.572 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 4.9 m . . . . . 0 CA--C 1.503 -0.863 0 CA-C-O 121.622 0.725 . . . . 0.0 110.67 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -93.41 -171.49 2.65 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.566 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 5.8 t -87.96 -176.92 5.63 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' ' 25' ' ' LEU . 72.5 ttt180 -94.89 111.99 23.74 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 122.333 1.063 . . . . 0.0 109.894 -178.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.558 ' O ' ' N ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -126.94 131.47 23.89 Favored Pre-proline 0 C--N 1.304 -1.394 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 177.383 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -46.93 95.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.301 -1.941 0 CA-C-N 120.894 1.355 . . . . 0.0 110.086 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.635 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -153.58 -164.35 1.87 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.008 -177.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.552 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 26.9 p -54.37 75.97 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.635 ' N ' ' O ' ' A' ' 8' ' ' ALA . 8.7 tp -69.77 -39.71 78.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.35 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.16 172.14 0.87 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.477 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.95 -24.34 28.98 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 -162.3 153.97 18.46 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 90.9 mtm-85 -103.25 155.83 18.16 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.018 0.437 . . . . 0.0 110.7 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 53.3 ptt85 -87.63 140.56 29.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.937 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -108.1 -65.15 1.14 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.092 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 26' ' ' TRP . . . -98.57 166.28 21.67 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.69 124.52 22.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.918 0.39 . . . . 0.0 110.663 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.566 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 14.1 p -101.09 130.04 47.07 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.0 mm -95.33 116.32 36.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.016 0.436 . . . . 0.0 109.943 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -166.45 126.87 1.65 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.434 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 55.69 12.54 0.84 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.176 0.512 . . . . 0.0 109.858 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.89 26.09 42.89 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.648 -0.581 . . . . 0.0 111.648 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.466 ' O ' ' O ' ' A' ' 19' ' ' CYS . 90.4 mtm180 -118.14 137.25 53.09 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.729 0.3 . . . . 0.0 110.634 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.826 ' N ' HD22 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -96.87 164.72 12.43 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.775 -179.292 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.478 ' CZ2' ' O ' ' A' ' 2' ' ' CYS . 25.8 t-105 -101.39 109.23 21.04 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 121.105 0.478 . . . . 0.0 111.167 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -114.83 147.72 39.47 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 176.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.404 ' CD2' ' SG ' ' A' ' 2' ' ' CYS . 9.3 m-85 -78.63 101.12 7.3 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.552 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 8.4 t -117.83 123.48 46.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.751 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.572 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 0.9 OUTLIER . . . . . 0 C--O 1.221 -0.437 0 CA-C-O 117.809 -1.091 . . . . 0.0 109.802 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.58 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 93.1 m . . . . . 0 CA--C 1.519 -0.239 0 CA-C-O 121.159 0.504 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -92.55 152.59 19.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.768 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 3.5 m -88.24 151.2 22.82 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.471 HH21 HG21 ' A' ' 10' ' ' ILE . 2.4 tpt180 -130.69 173.44 10.91 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 122.149 0.976 . . . . 0.0 111.363 -178.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.648 ' O ' ' N ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER -100.74 164.37 16.29 Favored Pre-proline 0 C--N 1.312 -1.03 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 177.059 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.401 ' HA ' ' HB2' ' A' ' 27' ' ' ALA . 74.7 Cg_exo -46.2 75.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.301 -1.935 0 C-N-CA 122.467 2.111 . . . . 0.0 114.057 -176.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.648 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -174.91 109.16 0.11 Allowed 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 113.551 -1.659 . . . . 0.0 108.61 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.526 ' SG ' ' O ' ' A' ' 13' ' ' GLU . 5.1 m -72.0 68.33 0.68 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.471 HG21 HH21 ' A' ' 5' ' ' ARG . 57.6 mt -68.88 -22.74 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-N 113.991 -1.459 . . . . 0.0 110.743 -178.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.503 ' HB2' ' C ' ' A' ' 30' ' ' CYS . . . -84.45 -43.69 14.38 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.236 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.5 41.67 1.12 Allowed Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.542 ' OE1' ' SG ' ' A' ' 30' ' ' CYS . 12.5 pt-20 -146.78 -173.91 4.34 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 81.5 mtm-85 -101.04 149.48 23.89 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.003 0.43 . . . . 0.0 112.137 -178.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.415 ' HB2' ' H ' ' A' ' 28' ' ' PHE . 47.0 ptt85 -91.09 128.66 37.0 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.859 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 91.9 t80 -147.22 -72.48 0.22 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.18 81.42 1.59 Allowed Glycine 0 CA--C 1.524 0.609 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.8 t -110.03 158.44 18.27 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.183 0.516 . . . . 0.0 110.647 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 0.7 OUTLIER -100.71 148.91 24.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.26 179.673 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.6 mm -94.27 119.0 41.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.019 0.437 . . . . 0.0 110.403 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -130.65 142.01 50.43 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.871 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 56.58 12.29 1.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.604 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.27 -1.16 71.67 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -93.09 149.99 20.84 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.641 0.258 . . . . 0.0 110.52 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.542 ' N ' HD12 ' A' ' 25' ' ' LEU . 10.7 mp -77.48 139.23 39.59 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.986 0.422 . . . . 0.0 110.315 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -109.63 142.24 41.04 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.668 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 5' ' ' ARG . . . -87.22 114.36 23.77 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 175.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.415 ' H ' ' HB2' ' A' ' 15' ' ' ARG . 13.7 t80 -75.82 99.87 4.58 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 118.062 -1.455 . . . . 0.0 107.19 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.505 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 1.2 m -141.35 123.62 15.68 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 113.515 -1.675 . . . . 0.0 108.932 -178.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.58 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 46.0 m . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 117.895 -1.05 . . . . 0.0 111.605 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.552 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 70.7 m . . . . . 0 N--CA 1.464 0.23 0 CA-C-O 120.824 0.345 . . . . 0.0 110.845 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.478 ' CD2' ' O ' ' A' ' 4' ' ' CYS . 58.7 t80 -92.4 152.18 19.86 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.564 ' HG ' ' HG ' ' A' ' 19' ' ' CYS . 33.6 m -88.48 148.52 24.13 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.823 0.344 . . . . 0.0 110.92 -178.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.408 ' HG3' ' H ' ' A' ' 6' ' ' ILE . 1.9 tpt180 -156.09 178.03 10.75 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.86 0.838 . . . . 0.0 111.041 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.662 ' O ' ' N ' ' A' ' 8' ' ' ALA . 0.7 OUTLIER -94.84 166.75 14.41 Favored Pre-proline 0 N--CA 1.439 -1.012 0 N-CA-C 103.318 -2.845 . . . . 0.0 103.318 177.216 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -50.86 54.88 0.02 OUTLIER 'Trans proline' 0 N--CA 1.507 2.317 0 C-N-CA 122.425 2.083 . . . . 0.0 115.88 -176.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.662 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -175.14 101.82 0.08 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.77 -0.196 . . . . 0.0 110.808 177.055 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.514 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 35.4 t 151.36 -8.24 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.564 HD11 ' HB1' ' A' ' 27' ' ' ALA . 8.3 mt -68.3 125.37 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 CA-C-N 114.277 -1.328 . . . . 0.0 109.585 -177.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.24 12.77 0.85 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.508 ' H ' ' C ' ' A' ' 10' ' ' ILE . . . 114.09 80.11 0.92 Allowed Glycine 0 CA--C 1.527 0.812 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.041 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -161.88 168.42 23.04 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 85.1 mmt-85 -103.78 158.82 16.13 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.962 0.411 . . . . 0.0 111.026 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.574 ' HA ' ' H ' ' A' ' 28' ' ' PHE . 33.2 ptt180 -70.71 127.65 33.38 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.492 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.503 ' CD2' ' N ' ' A' ' 17' ' ' GLY . 90.4 t80 -147.41 -91.16 0.09 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.574 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.503 ' N ' ' CD2' ' A' ' 16' ' ' TYR . . . -93.6 88.57 1.24 Allowed Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.415 HG22 ' H ' ' A' ' 19' ' ' CYS . 3.1 m -135.15 166.19 23.65 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.564 ' HG ' ' HG ' ' A' ' 4' ' ' CYS . 1.9 m -98.82 144.0 28.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.78 0.324 . . . . 0.0 110.17 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.408 HG23 ' O ' ' A' ' 24' ' ' ARG . 17.3 mm -96.73 120.95 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.648 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -114.14 136.59 52.77 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.544 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 59.76 12.18 2.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.202 0.525 . . . . 0.0 110.144 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.4 15.33 81.58 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.408 ' O ' HG23 ' A' ' 20' ' ' ILE . 89.8 mtm180 -92.57 152.76 19.43 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.622 0.249 . . . . 0.0 110.348 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.2 mt -76.84 124.05 27.14 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.24 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 6.9 m0 -111.35 143.12 42.65 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.318 0.58 . . . . 0.0 110.508 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.564 ' HB1' HD11 ' A' ' 10' ' ' ILE . . . -92.58 151.08 20.33 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.574 ' H ' ' HA ' ' A' ' 15' ' ' ARG . 61.5 t80 -80.04 105.07 11.04 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.536 0.684 . . . . 0.0 109.579 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.456 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 5.4 t -94.35 130.03 40.82 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.036 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.552 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 6.9 t . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.404 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' CYS . . . . . 0.517 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 24.8 p . . . . . 0 N--CA 1.462 0.134 0 CA-C-O 120.698 0.285 . . . . 0.0 110.282 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.484 ' CD2' ' O ' ' A' ' 3' ' ' TYR . 15.3 p90 -148.0 69.17 1.11 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.083 0.468 . . . . 0.0 110.481 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 2.1 m -153.19 172.89 16.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.845 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ARG . . . . . 0.771 ' C ' HD12 ' A' ' 6' ' ' ILE . 0.6 OUTLIER -101.9 131.56 48.19 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 177.463 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.771 HD12 ' C ' ' A' ' 5' ' ' ARG . 4.1 mp -145.52 131.74 9.67 Favored Pre-proline 0 C--N 1.304 -1.379 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -47.79 87.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.302 -1.902 0 N-CA-C 109.442 -1.022 . . . . 0.0 109.442 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.66 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -167.76 -160.9 0.36 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.239 -176.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 28.4 p -54.63 70.46 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.444 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.597 ' N ' ' O ' ' A' ' 8' ' ' ALA . 47.2 mt -68.23 -43.06 84.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.711 0.291 . . . . 0.0 110.446 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.57 171.9 4.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.697 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.98 -15.37 63.56 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.629 -0.989 . . . . 0.0 110.629 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 51.0 tp10 -157.67 147.17 20.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.814 0.34 . . . . 0.0 110.291 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.401 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 90.9 mtm-85 -103.41 169.19 8.69 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.504 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -68.51 134.02 49.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.218 0.532 . . . . 0.0 110.985 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' TYR . . . . . 0.401 ' CD2' ' O ' ' A' ' 14' ' ' ARG . 73.2 m-85 -147.19 -106.87 0.09 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.258 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.27 45.7 0.98 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.401 ' H ' ' C ' ' A' ' 16' ' ' TYR . 4.3 p -79.58 165.62 22.75 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 1.2 p -99.18 149.59 22.91 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 19.6 mm -80.4 122.11 35.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.267 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -147.99 145.22 28.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.241 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 52.33 12.75 0.24 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.717 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.59 20.11 78.67 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -136.32 152.26 50.48 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.756 0.312 . . . . 0.0 110.616 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 59.7 mt -82.36 130.51 35.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.117 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.42 ' HB3' ' H ' ' A' ' 5' ' ' ARG . 40.8 m0 -88.97 132.86 34.53 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.57 141.23 48.68 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -79.47 104.42 10.06 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.506 ' O ' ' SG ' ' A' ' 30' ' ' CYS . 44.8 t -94.47 134.6 36.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.977 -179.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.517 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 1.3 m . . . . . 0 C--O 1.221 -0.406 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.977 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.559 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 7.4 m -100.86 140.93 34.46 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.187 0.517 . . . . 0.0 110.461 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -92.63 -168.14 1.9 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.307 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.497 ' O ' HD13 ' A' ' 6' ' ' ILE . 0.7 OUTLIER -85.41 -174.67 5.32 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.139 -179.461 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -94.28 112.27 24.05 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-O 121.246 0.546 . . . . 0.0 109.829 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.65 ' O ' ' N ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -136.67 139.33 28.87 Favored Pre-proline 0 N--CA 1.439 -0.993 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.299 179.079 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -46.04 72.65 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.685 2.257 . . . . 0.0 112.685 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.65 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -143.33 -163.31 1.62 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.44 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.51 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 29.9 p -58.63 69.81 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.609 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.586 ' N ' ' O ' ' A' ' 8' ' ' ALA . 86.6 mt -77.75 -21.12 13.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.3 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.445 ' O ' ' O ' ' A' ' 10' ' ' ILE . . . -54.01 -164.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.608 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.8 -59.44 2.58 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.504 ' OE1' ' N ' ' A' ' 13' ' ' GLU . 58.0 mp0 -143.76 149.62 37.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.024 0.44 . . . . 0.0 110.562 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -127.35 116.56 20.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.079 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.518 ' NE ' ' CH2' ' A' ' 26' ' ' TRP . 14.3 tpt180 -78.61 137.85 38.05 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.259 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -84.84 -40.66 16.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.682 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.91 155.22 52.72 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.3 p -126.82 142.28 51.59 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.658 0.266 . . . . 0.0 110.373 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.518 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 12.9 p -102.46 119.23 38.47 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.217 0.532 . . . . 0.0 110.394 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.4 mm -90.23 96.8 6.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.156 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -146.89 106.09 3.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.107 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 40.2 tp60 63.6 14.29 7.98 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.051 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.23 33.69 19.54 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.491 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 96.1 mtt-85 -131.06 121.06 24.33 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.176 0.512 . . . . 0.0 110.574 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.434 ' N ' HD23 ' A' ' 25' ' ' LEU . 4.0 mt -87.38 167.1 14.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.41 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.605 ' O ' ' CG ' ' A' ' 26' ' ' TRP . 1.2 p-90 -113.73 109.94 19.37 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.572 0.701 . . . . 0.0 111.268 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -95.67 159.69 14.86 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -75.31 102.13 4.97 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.098 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.482 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 7.9 t -122.42 122.8 39.84 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.991 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.559 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 44.4 m . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 118.112 -0.947 . . . . 0.0 110.372 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.575 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 20.6 p -157.07 151.29 25.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.538 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.48 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 7.9 p90 -139.45 66.18 1.41 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.196 0.522 . . . . 0.0 111.15 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -154.49 174.53 14.79 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.396 177.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 70.9 ttp85 -99.43 114.74 27.85 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 121.67 0.748 . . . . 0.0 109.161 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.845 ' H ' HD12 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -137.19 133.11 18.26 Favored Pre-proline 0 C--N 1.305 -1.332 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 -179.896 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -47.19 85.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.302 -1.881 0 CA-C-N 119.725 0.938 . . . . 0.0 110.691 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.656 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -150.08 -164.83 2.11 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.491 -178.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.494 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 29.1 p -56.66 68.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.354 0.409 . . . . 0.0 111.162 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.598 ' N ' ' O ' ' A' ' 8' ' ' ALA . 4.9 mm -69.6 -25.44 28.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.753 0.311 . . . . 0.0 110.393 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.72 171.54 13.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.501 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.03 -17.79 58.61 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.548 ' OE2' ' CG ' ' A' ' 28' ' ' PHE . 72.6 tt0 -161.0 160.79 31.1 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 83.0 mmt-85 -103.39 157.26 17.15 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.133 0.492 . . . . 0.0 111.095 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.608 ' NH2' HG21 ' A' ' 18' ' ' THR . 9.3 ptm180 -84.04 140.24 31.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.85 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.616 ' O ' HG23 ' A' ' 18' ' ' THR . 84.8 t80 -146.65 -95.33 0.09 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.621 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.542 ' N ' ' CD2' ' A' ' 16' ' ' TYR . . . -60.56 77.04 0.01 OUTLIER Glycine 0 CA--C 1.522 0.499 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.616 HG23 ' O ' ' A' ' 16' ' ' TYR . 60.1 p -79.9 164.08 23.82 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.894 -0.323 . . . . 0.0 111.324 -178.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.44 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 14.1 p -118.71 126.18 51.32 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.207 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.453 ' H ' HD12 ' A' ' 20' ' ' ILE . 5.4 mp -86.62 97.71 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.418 ' C ' ' N ' ' A' ' 23' ' ' GLY . 67.6 m-85 -146.35 143.82 29.36 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.438 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 50.17 15.61 0.2 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.8 0.333 . . . . 0.0 110.586 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.418 ' N ' ' C ' ' A' ' 21' ' ' TYR . . . 76.13 25.67 65.89 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -128.26 140.95 51.61 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.986 0.422 . . . . 0.0 110.944 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.771 HD22 ' N ' ' A' ' 25' ' ' LEU . 2.2 mm? -89.62 157.85 17.86 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.529 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.541 ' CE3' ' O ' ' A' ' 17' ' ' GLY . 1.7 t90 -102.53 114.26 28.32 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.513 ' O ' ' CD1' ' A' ' 26' ' ' TRP . . . -89.42 152.69 21.35 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 177.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.548 ' CG ' ' OE2' ' A' ' 13' ' ' GLU . 0.8 OUTLIER -75.88 102.65 5.62 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 118.685 -1.206 . . . . 0.0 108.718 -178.547 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.44 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 12.9 t -108.0 153.83 22.52 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.318 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.575 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 2.6 m . . . . . 0 C--O 1.219 -0.507 0 CA-C-O 117.843 -1.075 . . . . 0.0 110.425 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 10.7 t -100.48 124.52 46.12 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.769 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.531 ' CD2' ' O ' ' A' ' 4' ' ' CYS . 56.8 t80 -102.99 151.5 22.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.346 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.553 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 2.7 m -88.17 154.08 20.73 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.595 HH21 HG21 ' A' ' 10' ' ' ILE . 3.5 tpt180 -138.06 174.17 10.85 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 122.029 0.919 . . . . 0.0 111.99 -178.176 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.628 ' O ' ' N ' ' A' ' 8' ' ' ALA . 1.9 pt -99.73 162.14 22.11 Favored Pre-proline 0 N--CA 1.44 -0.954 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 177.077 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.499 ' HA ' ' HB2' ' A' ' 27' ' ' ALA . 93.0 Cg_exo -47.86 76.27 0.01 OUTLIER 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 122.113 1.875 . . . . 0.0 113.813 -177.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.628 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -175.02 110.36 0.12 Allowed 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.16 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.539 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 55.8 m -70.46 70.3 0.42 Allowed 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.595 HG21 HH21 ' A' ' 5' ' ' ARG . 66.2 mt -66.28 -42.82 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-N 114.154 -1.384 . . . . 0.0 110.166 -178.262 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.22 -39.36 17.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.54 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.73 78.76 0.85 Allowed Glycine 0 CA--C 1.529 0.921 0 N-CA-C 111.815 -0.514 . . . . 0.0 111.815 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.516 ' O ' ' SG ' ' A' ' 9' ' ' CYS . 2.5 mm-40 -162.18 -179.18 6.86 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.987 0.422 . . . . 0.0 110.098 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -103.99 136.41 43.69 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.751 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.418 ' H ' ' HG2' ' A' ' 15' ' ' ARG . 31.7 ptt-85 -75.49 132.08 40.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.445 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.473 ' H ' ' HB3' ' A' ' 28' ' ' PHE . 29.8 m-85 -148.55 -103.29 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.09 65.79 1.22 Allowed Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.386 -1.085 . . . . 0.0 110.386 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 26' ' ' TRP . 8.9 t -79.43 163.94 24.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.963 0.411 . . . . 0.0 110.746 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.553 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 2.3 m -101.4 154.07 19.12 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.786 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.6 mm -96.0 116.29 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 120.957 0.408 . . . . 0.0 110.577 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -121.98 133.23 54.82 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.27 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 52.32 13.74 0.31 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.728 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.79 4.44 90.33 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -92.89 146.03 23.94 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.561 HD22 ' N ' ' A' ' 25' ' ' LEU . 3.4 mm? -76.86 136.24 38.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.119 0.485 . . . . 0.0 110.342 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.435 ' O ' ' OG1' ' A' ' 18' ' ' THR . 3.8 m95 -111.59 143.89 41.72 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.597 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.499 ' HB2' ' HA ' ' A' ' 7' ' ' PRO . . . -90.42 118.53 29.97 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 175.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.473 ' HB3' ' H ' ' A' ' 16' ' ' TYR . 26.0 t80 -76.99 100.03 5.49 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.539 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 1.3 m -130.13 126.28 37.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.46 -1.245 . . . . 0.0 109.43 -178.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 69.1 m . . . . . 0 C--O 1.218 -0.57 0 CA-C-O 118.101 -0.952 . . . . 0.0 111.556 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.581 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 16.7 p -152.85 158.7 42.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.303 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.503 ' O ' ' CD2' ' A' ' 3' ' ' TYR . 18.8 p90 -139.61 68.63 1.37 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.485 0.659 . . . . 0.0 110.773 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.478 ' C ' ' CD1' ' A' ' 26' ' ' TRP . 0.8 OUTLIER -151.28 179.14 8.57 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.303 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.487 HH11 ' CB ' ' A' ' 27' ' ' ALA . 57.7 ttt85 -95.59 122.36 38.26 Favored 'General case' 0 CA--C 1.489 -1.396 0 CA-C-O 122.485 1.136 . . . . 0.0 109.672 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.897 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -104.37 158.24 32.36 Favored Pre-proline 0 N--CA 1.416 -2.174 0 N-CA-C 102.58 -3.119 . . . . 0.0 102.58 176.75 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -61.82 24.66 0.05 OUTLIER 'Trans proline' 0 C--N 1.274 -3.346 0 C-N-CA 121.08 1.187 . . . . 0.0 111.985 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.665 ' H ' ' C ' ' A' ' 6' ' ' ILE . . . -155.27 108.91 2.83 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.544 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -62.85 99.29 0.15 Allowed 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 117.581 -1.648 . . . . 0.0 106.827 178.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.422 ' HB ' ' H ' ' A' ' 30' ' ' CYS . 96.3 mt -65.08 -43.46 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.317 -176.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.424 ' H ' ' HA ' ' A' ' 29' ' ' CYS . . . -77.52 -22.12 51.65 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.346 -0.541 . . . . 0.0 111.147 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.71 30.48 76.35 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.551 ' OE1' ' CD1' ' A' ' 28' ' ' PHE . 83.1 mt-10 -100.79 -175.82 3.0 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.367 0.603 . . . . 0.0 111.358 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 85.8 mtp180 -101.03 143.5 31.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.765 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.578 ' H ' ' HD2' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -68.41 142.13 55.49 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.297 -179.352 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.537 ' CD2' ' N ' ' A' ' 17' ' ' GLY . 70.6 t80 -148.63 -99.15 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.886 0.374 . . . . 0.0 110.868 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.537 ' N ' ' CD2' ' A' ' 16' ' ' TYR . . . -79.43 68.51 3.15 Favored Glycine 0 CA--C 1.52 0.347 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.442 HG22 ' O ' ' A' ' 26' ' ' TRP . 6.3 p -80.49 165.33 22.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.091 0.472 . . . . 0.0 111.991 -178.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.472 ' H ' ' HB3' ' A' ' 26' ' ' TRP . 9.4 p -100.03 139.22 36.01 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.126 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 21.0 mm -78.39 122.85 34.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.998 0.428 . . . . 0.0 110.316 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TYR . . . . . 0.424 ' C ' ' N ' ' A' ' 23' ' ' GLY . 86.5 t80 -153.53 128.69 9.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.582 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 43.2 tp60 51.87 12.39 0.19 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.07 0.462 . . . . 0.0 110.213 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.424 ' N ' ' C ' ' A' ' 21' ' ' TYR . . . 86.39 -2.26 87.44 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -98.26 135.1 40.37 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 76.1 mt -80.92 138.33 36.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.157 0.503 . . . . 0.0 110.562 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.701 ' CD1' ' O ' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -77.78 111.72 13.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.861 179.146 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.701 ' O ' ' CD1' ' A' ' 26' ' ' TRP . . . -66.39 149.14 50.84 Favored 'General case' 0 C--O 1.218 -0.605 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.037 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.551 ' CD1' ' OE1' ' A' ' 13' ' ' GLU . 3.0 t80 -73.24 104.07 4.16 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 118.691 -1.204 . . . . 0.0 110.027 -178.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.424 ' HA ' ' H ' ' A' ' 11' ' ' ALA . 12.7 m -122.29 164.85 17.18 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 113.382 -1.735 . . . . 0.0 109.292 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.581 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 5.2 m . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.01 -0.995 . . . . 0.0 111.027 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.48 ' SG ' ' N ' ' A' ' 16' ' ' TYR . 8.0 t -101.81 176.45 5.21 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.315 0.579 . . . . 0.0 110.988 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.552 ' N ' ' SG ' ' A' ' 30' ' ' CYS . 58.6 m-85 -131.45 151.58 51.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.248 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.584 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 56.7 m -87.78 -175.13 5.04 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.839 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 51.4 ttt85 -92.11 114.72 27.33 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 122.743 1.259 . . . . 0.0 111.065 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.6 ' O ' ' N ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -139.44 129.95 14.49 Favored Pre-proline 0 N--CA 1.426 -1.645 0 N-CA-C 103.268 -2.864 . . . . 0.0 103.268 176.097 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -47.4 90.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.295 -2.257 0 CA-C-N 121.002 1.394 . . . . 0.0 110.893 -177.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.6 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -146.85 -161.44 1.33 Allowed 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.792 -177.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.57 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 28.2 p -57.52 76.76 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.356 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.575 ' N ' ' O ' ' A' ' 8' ' ' ALA . 52.5 mt -68.66 -18.54 23.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.59 -164.67 1.16 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.028 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.06 -102.96 2.44 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.405 ' HG2' ' N ' ' A' ' 14' ' ' ARG . 77.6 tt0 -100.78 167.07 10.54 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.405 ' N ' ' HG2' ' A' ' 13' ' ' GLU . 85.1 mtm-85 -101.3 162.97 12.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.09 0.472 . . . . 0.0 110.921 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -67.29 134.56 51.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.874 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.48 ' N ' ' SG ' ' A' ' 2' ' ' CYS . 88.0 t80 -85.74 -15.56 41.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.292 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 178.03 110.02 0.26 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.459 HG22 ' H ' ' A' ' 18' ' ' THR . 0.0 OUTLIER -79.25 144.22 34.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.819 0.343 . . . . 0.0 110.63 -179.878 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.584 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 25.8 p -133.29 118.43 18.53 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.103 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.5 mt -87.98 139.15 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 CA-C-O 121.194 0.521 . . . . 0.0 110.877 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -149.47 115.15 5.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.493 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 50.56 33.77 8.52 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.699 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.69 36.03 7.03 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.784 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.422 ' C ' HD22 ' A' ' 25' ' ' LEU . 60.7 ttm-85 -90.41 132.38 35.65 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.238 0.542 . . . . 0.0 110.719 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.595 ' N ' HD22 ' A' ' 25' ' ' LEU . 3.6 mm? -95.64 163.15 13.32 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.538 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.413 ' CD1' ' OG1' ' A' ' 18' ' ' THR . 61.8 p-90 -122.16 138.91 54.3 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 122.074 0.94 . . . . 0.0 110.874 178.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -115.58 160.41 20.02 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 113.695 -1.593 . . . . 0.0 107.974 178.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.464 ' O ' ' O ' ' A' ' 10' ' ' ILE . 85.7 m-85 -75.22 100.76 4.42 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 178.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.57 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 8.6 t -139.01 -173.25 3.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.173 -176.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.552 ' SG ' ' N ' ' A' ' 3' ' ' TYR . 2.7 m . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.897 -1.049 . . . . 0.0 110.626 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 5.6 p -151.95 136.72 17.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.247 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.411 ' C ' ' CD1' ' A' ' 26' ' ' TRP . 42.1 m-85 -125.37 66.91 1.14 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.89 0.376 . . . . 0.0 110.641 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.557 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -153.37 173.68 15.33 Favored 'General case' 0 C--O 1.214 -0.764 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.707 HH11 ' NH2' ' A' ' 15' ' ' ARG . 62.4 ttp180 -100.09 111.47 23.76 Favored 'General case' 0 CA--C 1.479 -1.782 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.552 ' O ' ' N ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -108.39 158.78 32.95 Favored Pre-proline 0 C--N 1.299 -1.605 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 178.948 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -48.9 -6.18 0.05 OUTLIER 'Trans proline' 0 C--N 1.28 -3.069 0 C-N-CA 120.76 0.974 . . . . 0.0 112.193 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -127.41 105.79 8.76 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.299 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.621 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 1.7 p 155.25 5.19 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.1 mm -66.73 -42.51 89.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 C-N-CA 119.624 -0.831 . . . . 0.0 109.112 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -101.76 154.41 18.93 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.881 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.83 6.2 85.54 Favored Glycine 0 N--CA 1.466 0.649 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.55 ' CG ' ' O ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER -163.22 -176.8 5.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.815 0.34 . . . . 0.0 110.588 -179.002 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -131.82 152.67 50.83 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.682 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.707 ' NH2' HH11 ' A' ' 5' ' ' ARG . 42.0 ttm180 -86.21 100.43 12.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.808 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -102.08 -101.7 0.27 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.88 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.533 ' O ' ' CE3' ' A' ' 26' ' ' TRP . . . -59.22 112.32 4.12 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.477 ' HA ' ' H ' ' A' ' 26' ' ' TRP . 0.1 OUTLIER -102.44 123.8 46.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.951 0.405 . . . . 0.0 110.419 -179.488 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.497 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 7.3 p -101.72 131.69 47.85 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.029 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 15.3 mm -84.65 113.82 23.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 C-N-CA 120.224 -0.59 . . . . 0.0 109.789 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -149.13 114.88 5.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.172 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 49.1 21.42 0.49 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.49 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.83 29.53 26.02 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' A' ' 19' ' ' CYS . 99.7 mtt180 -124.88 122.24 36.82 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.819 0.342 . . . . 0.0 110.932 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.4 mt -80.27 162.56 24.54 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.736 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.533 ' CE3' ' O ' ' A' ' 17' ' ' GLY . 1.7 t90 -97.02 116.5 29.33 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.026 0.441 . . . . 0.0 110.022 178.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.446 ' O ' ' CD1' ' A' ' 26' ' ' TRP . . . -96.53 151.73 19.3 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.427 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 47.0 t80 -75.94 101.07 5.05 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 118.736 -1.186 . . . . 0.0 108.612 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.621 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 61.4 m -96.16 144.12 26.68 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.869 -178.135 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 2.6 m . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.399 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.652 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.572 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 4.9 m -100.04 142.79 31.04 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-O 121.622 0.725 . . . . 0.0 110.67 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -93.41 -171.49 2.65 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.566 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 5.8 t -87.96 -176.92 5.63 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' ' 25' ' ' LEU . 72.5 ttt180 -94.89 111.99 23.74 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 122.333 1.063 . . . . 0.0 109.894 -178.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.558 ' O ' ' N ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -126.94 131.47 23.89 Favored Pre-proline 0 C--N 1.304 -1.394 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 177.383 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -46.93 95.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.301 -1.941 0 CA-C-N 120.894 1.355 . . . . 0.0 110.086 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.635 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -153.58 -164.35 1.87 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.008 -177.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.552 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 26.9 p -54.37 75.97 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.635 ' N ' ' O ' ' A' ' 8' ' ' ALA . 8.7 tp -69.77 -39.71 78.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.35 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.16 172.14 0.87 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.477 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.95 -24.34 28.98 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 -162.3 153.97 18.46 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 90.9 mtm-85 -103.25 155.83 18.16 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.018 0.437 . . . . 0.0 110.7 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 53.3 ptt85 -87.63 140.56 29.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.937 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -108.1 -65.15 1.14 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.092 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 26' ' ' TRP . . . -98.57 166.28 21.67 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.69 124.52 22.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.918 0.39 . . . . 0.0 110.663 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.566 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 14.1 p -101.09 130.04 47.07 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.0 mm -95.33 116.32 36.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.016 0.436 . . . . 0.0 109.943 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -166.45 126.87 1.65 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.434 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 55.69 12.54 0.84 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.176 0.512 . . . . 0.0 109.858 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.89 26.09 42.89 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.648 -0.581 . . . . 0.0 111.648 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.466 ' O ' ' O ' ' A' ' 19' ' ' CYS . 90.4 mtm180 -118.14 137.25 53.09 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.729 0.3 . . . . 0.0 110.634 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.826 ' N ' HD22 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -96.87 164.72 12.43 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.775 -179.292 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.478 ' CZ2' ' O ' ' A' ' 2' ' ' CYS . 25.8 t-105 -101.39 109.23 21.04 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 121.105 0.478 . . . . 0.0 111.167 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -114.83 147.72 39.47 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 176.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.404 ' CD2' ' SG ' ' A' ' 2' ' ' CYS . 9.3 m-85 -78.63 101.12 7.3 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.552 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 8.4 t -117.83 123.48 46.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.751 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.572 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 0.9 OUTLIER . . . . . 0 C--O 1.221 -0.437 0 CA-C-O 117.809 -1.091 . . . . 0.0 109.802 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.58 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 93.1 m -101.2 128.12 47.45 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.159 0.504 . . . . 0.0 110.943 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -92.55 152.59 19.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.768 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 3.5 m -88.24 151.2 22.82 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.471 HH21 HG21 ' A' ' 10' ' ' ILE . 2.4 tpt180 -130.69 173.44 10.91 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 122.149 0.976 . . . . 0.0 111.363 -178.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.648 ' O ' ' N ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER -100.74 164.37 16.29 Favored Pre-proline 0 C--N 1.312 -1.03 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 177.059 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.401 ' HA ' ' HB2' ' A' ' 27' ' ' ALA . 74.7 Cg_exo -46.2 75.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.301 -1.935 0 C-N-CA 122.467 2.111 . . . . 0.0 114.057 -176.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.648 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -174.91 109.16 0.11 Allowed 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 113.551 -1.659 . . . . 0.0 108.61 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.526 ' SG ' ' O ' ' A' ' 13' ' ' GLU . 5.1 m -72.0 68.33 0.68 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.471 HG21 HH21 ' A' ' 5' ' ' ARG . 57.6 mt -68.88 -22.74 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-N 113.991 -1.459 . . . . 0.0 110.743 -178.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.503 ' HB2' ' C ' ' A' ' 30' ' ' CYS . . . -84.45 -43.69 14.38 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.236 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.5 41.67 1.12 Allowed Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.542 ' OE1' ' SG ' ' A' ' 30' ' ' CYS . 12.5 pt-20 -146.78 -173.91 4.34 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 81.5 mtm-85 -101.04 149.48 23.89 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.003 0.43 . . . . 0.0 112.137 -178.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.415 ' HB2' ' H ' ' A' ' 28' ' ' PHE . 47.0 ptt85 -91.09 128.66 37.0 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.859 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 91.9 t80 -147.22 -72.48 0.22 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.18 81.42 1.59 Allowed Glycine 0 CA--C 1.524 0.609 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.8 t -110.03 158.44 18.27 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.183 0.516 . . . . 0.0 110.647 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 0.7 OUTLIER -100.71 148.91 24.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.26 179.673 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.6 mm -94.27 119.0 41.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.019 0.437 . . . . 0.0 110.403 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -130.65 142.01 50.43 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.871 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 56.58 12.29 1.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.604 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.27 -1.16 71.67 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -93.09 149.99 20.84 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.641 0.258 . . . . 0.0 110.52 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.542 ' N ' HD12 ' A' ' 25' ' ' LEU . 10.7 mp -77.48 139.23 39.59 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.986 0.422 . . . . 0.0 110.315 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -109.63 142.24 41.04 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.668 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 5' ' ' ARG . . . -87.22 114.36 23.77 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 175.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.415 ' H ' ' HB2' ' A' ' 15' ' ' ARG . 13.7 t80 -75.82 99.87 4.58 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 118.062 -1.455 . . . . 0.0 107.19 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.505 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 1.2 m -141.35 123.62 15.68 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 113.515 -1.675 . . . . 0.0 108.932 -178.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.58 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 46.0 m . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 117.895 -1.05 . . . . 0.0 111.605 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.552 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 70.7 m -100.87 131.67 46.64 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.845 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.478 ' CD2' ' O ' ' A' ' 4' ' ' CYS . 58.7 t80 -92.4 152.18 19.86 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.564 ' HG ' ' HG ' ' A' ' 19' ' ' CYS . 33.6 m -88.48 148.52 24.13 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.823 0.344 . . . . 0.0 110.92 -178.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.408 ' HG3' ' H ' ' A' ' 6' ' ' ILE . 1.9 tpt180 -156.09 178.03 10.75 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.86 0.838 . . . . 0.0 111.041 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.662 ' O ' ' N ' ' A' ' 8' ' ' ALA . 0.7 OUTLIER -94.84 166.75 14.41 Favored Pre-proline 0 N--CA 1.439 -1.012 0 N-CA-C 103.318 -2.845 . . . . 0.0 103.318 177.216 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -50.86 54.88 0.02 OUTLIER 'Trans proline' 0 N--CA 1.507 2.317 0 C-N-CA 122.425 2.083 . . . . 0.0 115.88 -176.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.662 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -175.14 101.82 0.08 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.77 -0.196 . . . . 0.0 110.808 177.055 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.514 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 35.4 t 151.36 -8.24 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.564 HD11 ' HB1' ' A' ' 27' ' ' ALA . 8.3 mt -68.3 125.37 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 CA-C-N 114.277 -1.328 . . . . 0.0 109.585 -177.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.24 12.77 0.85 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.508 ' H ' ' C ' ' A' ' 10' ' ' ILE . . . 114.09 80.11 0.92 Allowed Glycine 0 CA--C 1.527 0.812 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.041 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -161.88 168.42 23.04 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 85.1 mmt-85 -103.78 158.82 16.13 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.962 0.411 . . . . 0.0 111.026 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.574 ' HA ' ' H ' ' A' ' 28' ' ' PHE . 33.2 ptt180 -70.71 127.65 33.38 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.492 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.503 ' CD2' ' N ' ' A' ' 17' ' ' GLY . 90.4 t80 -147.41 -91.16 0.09 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.574 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.503 ' N ' ' CD2' ' A' ' 16' ' ' TYR . . . -93.6 88.57 1.24 Allowed Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.415 HG22 ' H ' ' A' ' 19' ' ' CYS . 3.1 m -135.15 166.19 23.65 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.564 ' HG ' ' HG ' ' A' ' 4' ' ' CYS . 1.9 m -98.82 144.0 28.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.78 0.324 . . . . 0.0 110.17 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.408 HG23 ' O ' ' A' ' 24' ' ' ARG . 17.3 mm -96.73 120.95 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.648 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -114.14 136.59 52.77 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.544 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 59.76 12.18 2.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.202 0.525 . . . . 0.0 110.144 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.4 15.33 81.58 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.408 ' O ' HG23 ' A' ' 20' ' ' ILE . 89.8 mtm180 -92.57 152.76 19.43 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.622 0.249 . . . . 0.0 110.348 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.2 mt -76.84 124.05 27.14 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.24 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 6.9 m0 -111.35 143.12 42.65 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.318 0.58 . . . . 0.0 110.508 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.564 ' HB1' HD11 ' A' ' 10' ' ' ILE . . . -92.58 151.08 20.33 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.574 ' H ' ' HA ' ' A' ' 15' ' ' ARG . 61.5 t80 -80.04 105.07 11.04 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.536 0.684 . . . . 0.0 109.579 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.456 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 5.4 t -94.35 130.03 40.82 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.036 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.552 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 6.9 t . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.404 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' CYS . . . . . 0.517 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 24.8 p -152.69 155.11 36.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.282 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.484 ' CD2' ' O ' ' A' ' 3' ' ' TYR . 15.3 p90 -148.0 69.17 1.11 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.083 0.468 . . . . 0.0 110.481 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 2.1 m -153.19 172.89 16.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.845 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ARG . . . . . 0.771 ' C ' HD12 ' A' ' 6' ' ' ILE . 0.6 OUTLIER -101.9 131.56 48.19 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 177.463 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.771 HD12 ' C ' ' A' ' 5' ' ' ARG . 4.1 mp -145.52 131.74 9.67 Favored Pre-proline 0 C--N 1.304 -1.379 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -47.79 87.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.302 -1.902 0 N-CA-C 109.442 -1.022 . . . . 0.0 109.442 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.66 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -167.76 -160.9 0.36 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.239 -176.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.503 ' SG ' ' O ' ' A' ' 9' ' ' CYS . 28.4 p -54.63 70.46 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.444 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.597 ' N ' ' O ' ' A' ' 8' ' ' ALA . 47.2 mt -68.23 -43.06 84.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.711 0.291 . . . . 0.0 110.446 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.57 171.9 4.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.697 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.98 -15.37 63.56 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.629 -0.989 . . . . 0.0 110.629 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 51.0 tp10 -157.67 147.17 20.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.814 0.34 . . . . 0.0 110.291 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.401 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 90.9 mtm-85 -103.41 169.19 8.69 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.504 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -68.51 134.02 49.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.218 0.532 . . . . 0.0 110.985 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' TYR . . . . . 0.401 ' CD2' ' O ' ' A' ' 14' ' ' ARG . 73.2 m-85 -147.19 -106.87 0.09 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.258 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.27 45.7 0.98 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.401 ' H ' ' C ' ' A' ' 16' ' ' TYR . 4.3 p -79.58 165.62 22.75 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 1.2 p -99.18 149.59 22.91 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 19.6 mm -80.4 122.11 35.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.267 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -147.99 145.22 28.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.241 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 52.33 12.75 0.24 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.717 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.59 20.11 78.67 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -136.32 152.26 50.48 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.756 0.312 . . . . 0.0 110.616 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 59.7 mt -82.36 130.51 35.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.117 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.42 ' HB3' ' H ' ' A' ' 5' ' ' ARG . 40.8 m0 -88.97 132.86 34.53 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.57 141.23 48.68 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -79.47 104.42 10.06 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.506 ' O ' ' SG ' ' A' ' 30' ' ' CYS . 44.8 t -94.47 134.6 36.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.977 -179.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.517 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 1.3 m . . . . . 0 C--O 1.221 -0.406 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.977 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.559 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 7.4 m . . . . . 0 N--CA 1.469 0.484 0 CA-C-O 121.187 0.517 . . . . 0.0 110.461 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -92.63 -168.14 1.9 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.307 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.497 ' O ' HD13 ' A' ' 6' ' ' ILE . 0.7 OUTLIER -85.41 -174.67 5.32 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.139 -179.461 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -94.28 112.27 24.05 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-O 121.246 0.546 . . . . 0.0 109.829 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.65 ' O ' ' N ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -136.67 139.33 28.87 Favored Pre-proline 0 N--CA 1.439 -0.993 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.299 179.079 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -46.04 72.65 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.685 2.257 . . . . 0.0 112.685 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.65 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -143.33 -163.31 1.62 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.44 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.51 ' O ' ' SG ' ' A' ' 9' ' ' CYS . 29.9 p -58.63 69.81 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.609 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.586 ' N ' ' O ' ' A' ' 8' ' ' ALA . 86.6 mt -77.75 -21.12 13.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.3 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.445 ' O ' ' O ' ' A' ' 10' ' ' ILE . . . -54.01 -164.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.608 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.8 -59.44 2.58 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.504 ' N ' ' OE1' ' A' ' 13' ' ' GLU . 58.0 mp0 -143.76 149.62 37.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.024 0.44 . . . . 0.0 110.562 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -127.35 116.56 20.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.079 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.518 ' NE ' ' CH2' ' A' ' 26' ' ' TRP . 14.3 tpt180 -78.61 137.85 38.05 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.259 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -84.84 -40.66 16.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.682 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.91 155.22 52.72 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.3 p -126.82 142.28 51.59 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.658 0.266 . . . . 0.0 110.373 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.518 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 12.9 p -102.46 119.23 38.47 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.217 0.532 . . . . 0.0 110.394 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.4 mm -90.23 96.8 6.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.156 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -146.89 106.09 3.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.107 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 40.2 tp60 63.6 14.29 7.98 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.051 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.23 33.69 19.54 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.491 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 96.1 mtt-85 -131.06 121.06 24.33 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.176 0.512 . . . . 0.0 110.574 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.434 HD23 ' N ' ' A' ' 25' ' ' LEU . 4.0 mt -87.38 167.1 14.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.41 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.605 ' CG ' ' O ' ' A' ' 26' ' ' TRP . 1.2 p-90 -113.73 109.94 19.37 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.572 0.701 . . . . 0.0 111.268 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -95.67 159.69 14.86 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -75.31 102.13 4.97 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.098 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.482 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 7.9 t -122.42 122.8 39.84 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.991 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.559 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 44.4 m . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 118.112 -0.947 . . . . 0.0 110.372 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.575 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 20.6 p . . . . . 0 CA--C 1.52 -0.208 0 CA-C-O 120.681 0.277 . . . . 0.0 110.538 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.48 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 7.9 p90 -139.45 66.18 1.41 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.196 0.522 . . . . 0.0 111.15 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -154.49 174.53 14.79 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.396 177.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 70.9 ttp85 -99.43 114.74 27.85 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 121.67 0.748 . . . . 0.0 109.161 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.845 ' H ' HD12 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -137.19 133.11 18.26 Favored Pre-proline 0 C--N 1.305 -1.332 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 -179.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -47.19 85.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.302 -1.881 0 CA-C-N 119.725 0.938 . . . . 0.0 110.691 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.656 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -150.08 -164.83 2.11 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.491 -178.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.494 ' O ' ' SG ' ' A' ' 9' ' ' CYS . 29.1 p -56.66 68.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.354 0.409 . . . . 0.0 111.162 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.598 ' N ' ' O ' ' A' ' 8' ' ' ALA . 4.9 mm -69.6 -25.44 28.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.753 0.311 . . . . 0.0 110.393 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.72 171.54 13.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.501 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.03 -17.79 58.61 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.548 ' OE2' ' CG ' ' A' ' 28' ' ' PHE . 72.6 tt0 -161.0 160.79 31.1 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 83.0 mmt-85 -103.39 157.26 17.15 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.133 0.492 . . . . 0.0 111.095 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.608 ' NH2' HG21 ' A' ' 18' ' ' THR . 9.3 ptm180 -84.04 140.24 31.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.85 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.616 ' O ' HG23 ' A' ' 18' ' ' THR . 84.8 t80 -146.65 -95.33 0.09 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.621 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.542 ' N ' ' CD2' ' A' ' 16' ' ' TYR . . . -60.56 77.04 0.01 OUTLIER Glycine 0 CA--C 1.522 0.499 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.616 HG23 ' O ' ' A' ' 16' ' ' TYR . 60.1 p -79.9 164.08 23.82 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.894 -0.323 . . . . 0.0 111.324 -178.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.44 ' H ' ' HB3' ' A' ' 26' ' ' TRP . 14.1 p -118.71 126.18 51.32 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.207 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.453 ' H ' HD12 ' A' ' 20' ' ' ILE . 5.4 mp -86.62 97.71 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.418 ' C ' ' N ' ' A' ' 23' ' ' GLY . 67.6 m-85 -146.35 143.82 29.36 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.438 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 50.17 15.61 0.2 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.8 0.333 . . . . 0.0 110.586 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.418 ' N ' ' C ' ' A' ' 21' ' ' TYR . . . 76.13 25.67 65.89 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -128.26 140.95 51.61 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.986 0.422 . . . . 0.0 110.944 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.771 ' N ' HD22 ' A' ' 25' ' ' LEU . 2.2 mm? -89.62 157.85 17.86 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.529 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.541 ' CE3' ' O ' ' A' ' 17' ' ' GLY . 1.7 t90 -102.53 114.26 28.32 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.513 ' O ' ' CD1' ' A' ' 26' ' ' TRP . . . -89.42 152.69 21.35 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 177.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.548 ' CG ' ' OE2' ' A' ' 13' ' ' GLU . 0.8 OUTLIER -75.88 102.65 5.62 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 118.685 -1.206 . . . . 0.0 108.718 -178.547 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.44 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 12.9 t -108.0 153.83 22.52 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.318 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.575 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 2.6 m . . . . . 0 C--O 1.219 -0.507 0 CA-C-O 117.843 -1.075 . . . . 0.0 110.425 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 10.7 t . . . . . 0 CA--C 1.519 -0.247 0 CA-C-O 120.981 0.42 . . . . 0.0 110.769 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.531 ' CD2' ' O ' ' A' ' 4' ' ' CYS . 56.8 t80 -102.99 151.5 22.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.346 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.553 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 2.7 m -88.17 154.08 20.73 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.595 HH21 HG21 ' A' ' 10' ' ' ILE . 3.5 tpt180 -138.06 174.17 10.85 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 122.029 0.919 . . . . 0.0 111.99 -178.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.628 ' O ' ' N ' ' A' ' 8' ' ' ALA . 1.9 pt -99.73 162.14 22.11 Favored Pre-proline 0 N--CA 1.44 -0.954 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 177.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.499 ' HA ' ' HB2' ' A' ' 27' ' ' ALA . 93.0 Cg_exo -47.86 76.27 0.01 OUTLIER 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 122.113 1.875 . . . . 0.0 113.813 -177.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.628 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -175.02 110.36 0.12 Allowed 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.16 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.539 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 55.8 m -70.46 70.3 0.42 Allowed 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.595 HG21 HH21 ' A' ' 5' ' ' ARG . 66.2 mt -66.28 -42.82 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-N 114.154 -1.384 . . . . 0.0 110.166 -178.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.22 -39.36 17.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.54 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.73 78.76 0.85 Allowed Glycine 0 CA--C 1.529 0.921 0 N-CA-C 111.815 -0.514 . . . . 0.0 111.815 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.516 ' O ' ' SG ' ' A' ' 9' ' ' CYS . 2.5 mm-40 -162.18 -179.18 6.86 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.987 0.422 . . . . 0.0 110.098 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -103.99 136.41 43.69 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.751 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.418 ' H ' ' HG2' ' A' ' 15' ' ' ARG . 31.7 ptt-85 -75.49 132.08 40.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.445 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.473 ' H ' ' HB3' ' A' ' 28' ' ' PHE . 29.8 m-85 -148.55 -103.29 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.09 65.79 1.22 Allowed Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.386 -1.085 . . . . 0.0 110.386 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 26' ' ' TRP . 8.9 t -79.43 163.94 24.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.963 0.411 . . . . 0.0 110.746 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.553 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 2.3 m -101.4 154.07 19.12 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.786 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.6 mm -96.0 116.29 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 120.957 0.408 . . . . 0.0 110.577 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -121.98 133.23 54.82 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.27 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 52.32 13.74 0.31 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.728 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.79 4.44 90.33 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -92.89 146.03 23.94 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.561 ' N ' HD22 ' A' ' 25' ' ' LEU . 3.4 mm? -76.86 136.24 38.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.119 0.485 . . . . 0.0 110.342 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.435 ' O ' ' OG1' ' A' ' 18' ' ' THR . 3.8 m95 -111.59 143.89 41.72 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.597 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.499 ' HB2' ' HA ' ' A' ' 7' ' ' PRO . . . -90.42 118.53 29.97 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 175.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.473 ' HB3' ' H ' ' A' ' 16' ' ' TYR . 26.0 t80 -76.99 100.03 5.49 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.539 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 1.3 m -130.13 126.28 37.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.46 -1.245 . . . . 0.0 109.43 -178.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 69.1 m . . . . . 0 C--O 1.218 -0.57 0 CA-C-O 118.101 -0.952 . . . . 0.0 111.556 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.581 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 16.7 p . . . . . 0 C--O 1.232 0.161 0 CA-C-O 120.655 0.264 . . . . 0.0 110.303 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.503 ' CD2' ' O ' ' A' ' 3' ' ' TYR . 18.8 p90 -139.61 68.63 1.37 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.485 0.659 . . . . 0.0 110.773 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.478 ' C ' ' CD1' ' A' ' 26' ' ' TRP . 0.8 OUTLIER -151.28 179.14 8.57 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.303 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.487 HH11 ' CB ' ' A' ' 27' ' ' ALA . 57.7 ttt85 -95.59 122.36 38.26 Favored 'General case' 0 CA--C 1.489 -1.396 0 CA-C-O 122.485 1.136 . . . . 0.0 109.672 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.897 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -104.37 158.24 32.36 Favored Pre-proline 0 N--CA 1.416 -2.174 0 N-CA-C 102.58 -3.119 . . . . 0.0 102.58 176.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -61.82 24.66 0.05 OUTLIER 'Trans proline' 0 C--N 1.274 -3.346 0 C-N-CA 121.08 1.187 . . . . 0.0 111.985 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.665 ' H ' ' C ' ' A' ' 6' ' ' ILE . . . -155.27 108.91 2.83 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.544 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -62.85 99.29 0.15 Allowed 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 117.581 -1.648 . . . . 0.0 106.827 178.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.422 ' HB ' ' H ' ' A' ' 30' ' ' CYS . 96.3 mt -65.08 -43.46 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.317 -176.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.424 ' H ' ' HA ' ' A' ' 29' ' ' CYS . . . -77.52 -22.12 51.65 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.346 -0.541 . . . . 0.0 111.147 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.71 30.48 76.35 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.551 ' OE1' ' CD1' ' A' ' 28' ' ' PHE . 83.1 mt-10 -100.79 -175.82 3.0 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.367 0.603 . . . . 0.0 111.358 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 85.8 mtp180 -101.03 143.5 31.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.765 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.578 ' HD2' ' H ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -68.41 142.13 55.49 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.297 -179.352 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.537 ' CD2' ' N ' ' A' ' 17' ' ' GLY . 70.6 t80 -148.63 -99.15 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.886 0.374 . . . . 0.0 110.868 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.537 ' N ' ' CD2' ' A' ' 16' ' ' TYR . . . -79.43 68.51 3.15 Favored Glycine 0 CA--C 1.52 0.347 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.442 HG22 ' O ' ' A' ' 26' ' ' TRP . 6.3 p -80.49 165.33 22.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.091 0.472 . . . . 0.0 111.991 -178.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.472 ' H ' ' HB3' ' A' ' 26' ' ' TRP . 9.4 p -100.03 139.22 36.01 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.126 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 21.0 mm -78.39 122.85 34.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.998 0.428 . . . . 0.0 110.316 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . 0.424 ' C ' ' N ' ' A' ' 23' ' ' GLY . 86.5 t80 -153.53 128.69 9.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.582 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 43.2 tp60 51.87 12.39 0.19 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.07 0.462 . . . . 0.0 110.213 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.424 ' N ' ' C ' ' A' ' 21' ' ' TYR . . . 86.39 -2.26 87.44 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -98.26 135.1 40.37 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 76.1 mt -80.92 138.33 36.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.157 0.503 . . . . 0.0 110.562 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.701 ' CD1' ' O ' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -77.78 111.72 13.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.861 179.146 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.701 ' O ' ' CD1' ' A' ' 26' ' ' TRP . . . -66.39 149.14 50.84 Favored 'General case' 0 C--O 1.218 -0.605 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.551 ' CD1' ' OE1' ' A' ' 13' ' ' GLU . 3.0 t80 -73.24 104.07 4.16 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 118.691 -1.204 . . . . 0.0 110.027 -178.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.424 ' HA ' ' H ' ' A' ' 11' ' ' ALA . 12.7 m -122.29 164.85 17.18 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 113.382 -1.735 . . . . 0.0 109.292 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.581 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 5.2 m . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.01 -0.995 . . . . 0.0 111.027 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.48 ' SG ' ' N ' ' A' ' 16' ' ' TYR . 8.0 t . . . . . 0 CA--C 1.512 -0.486 0 CA-C-O 121.315 0.579 . . . . 0.0 110.988 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.552 ' N ' ' SG ' ' A' ' 30' ' ' CYS . 58.6 m-85 -131.45 151.58 51.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.248 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.584 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 56.7 m -87.78 -175.13 5.04 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.839 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 51.4 ttt85 -92.11 114.72 27.33 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 122.743 1.259 . . . . 0.0 111.065 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.6 ' O ' ' N ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -139.44 129.95 14.49 Favored Pre-proline 0 N--CA 1.426 -1.645 0 N-CA-C 103.268 -2.864 . . . . 0.0 103.268 176.097 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -47.4 90.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.295 -2.257 0 CA-C-N 121.002 1.394 . . . . 0.0 110.893 -177.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.6 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -146.85 -161.44 1.33 Allowed 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.792 -177.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.57 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 28.2 p -57.52 76.76 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.356 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.575 ' N ' ' O ' ' A' ' 8' ' ' ALA . 52.5 mt -68.66 -18.54 23.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.59 -164.67 1.16 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.028 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.06 -102.96 2.44 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.405 ' HG2' ' N ' ' A' ' 14' ' ' ARG . 77.6 tt0 -100.78 167.07 10.54 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.405 ' N ' ' HG2' ' A' ' 13' ' ' GLU . 85.1 mtm-85 -101.3 162.97 12.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.09 0.472 . . . . 0.0 110.921 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -67.29 134.56 51.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.874 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.48 ' N ' ' SG ' ' A' ' 2' ' ' CYS . 88.0 t80 -85.74 -15.56 41.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.292 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 178.03 110.02 0.26 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.459 ' H ' HG22 ' A' ' 18' ' ' THR . 0.0 OUTLIER -79.25 144.22 34.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.819 0.343 . . . . 0.0 110.63 -179.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.584 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 25.8 p -133.29 118.43 18.53 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.103 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.5 mt -87.98 139.15 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 CA-C-O 121.194 0.521 . . . . 0.0 110.877 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -149.47 115.15 5.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.493 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 50.56 33.77 8.52 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.699 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.69 36.03 7.03 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.784 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.422 ' C ' HD22 ' A' ' 25' ' ' LEU . 60.7 ttm-85 -90.41 132.38 35.65 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.238 0.542 . . . . 0.0 110.719 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.595 HD22 ' N ' ' A' ' 25' ' ' LEU . 3.6 mm? -95.64 163.15 13.32 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.538 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.413 ' CD1' ' OG1' ' A' ' 18' ' ' THR . 61.8 p-90 -122.16 138.91 54.3 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 122.074 0.94 . . . . 0.0 110.874 178.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -115.58 160.41 20.02 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 113.695 -1.593 . . . . 0.0 107.974 178.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.464 ' O ' ' O ' ' A' ' 10' ' ' ILE . 85.7 m-85 -75.22 100.76 4.42 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 178.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.57 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 8.6 t -139.01 -173.25 3.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.173 -176.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.552 ' SG ' ' N ' ' A' ' 3' ' ' TYR . 2.7 m . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.897 -1.049 . . . . 0.0 110.626 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 5.6 p . . . . . 0 CA--C 1.522 -0.134 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.411 ' C ' ' CD1' ' A' ' 26' ' ' TRP . 42.1 m-85 -125.37 66.91 1.14 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.89 0.376 . . . . 0.0 110.641 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.557 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -153.37 173.68 15.33 Favored 'General case' 0 C--O 1.214 -0.764 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.707 HH11 ' NH2' ' A' ' 15' ' ' ARG . 62.4 ttp180 -100.09 111.47 23.76 Favored 'General case' 0 CA--C 1.479 -1.782 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.552 ' O ' ' N ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -108.39 158.78 32.95 Favored Pre-proline 0 C--N 1.299 -1.605 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 178.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -48.9 -6.18 0.05 OUTLIER 'Trans proline' 0 C--N 1.28 -3.069 0 C-N-CA 120.76 0.974 . . . . 0.0 112.193 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -127.41 105.79 8.76 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.299 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.621 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 1.7 p 155.25 5.19 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.1 mm -66.73 -42.51 89.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 C-N-CA 119.624 -0.831 . . . . 0.0 109.112 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -101.76 154.41 18.93 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.881 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.83 6.2 85.54 Favored Glycine 0 N--CA 1.466 0.649 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.55 ' CG ' ' O ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER -163.22 -176.8 5.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.815 0.34 . . . . 0.0 110.588 -179.002 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -131.82 152.67 50.83 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.682 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.707 ' NH2' HH11 ' A' ' 5' ' ' ARG . 42.0 ttm180 -86.21 100.43 12.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.808 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -102.08 -101.7 0.27 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.88 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.533 ' O ' ' CE3' ' A' ' 26' ' ' TRP . . . -59.22 112.32 4.12 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.477 ' HA ' ' H ' ' A' ' 26' ' ' TRP . 0.1 OUTLIER -102.44 123.8 46.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.951 0.405 . . . . 0.0 110.419 -179.488 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.497 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 7.3 p -101.72 131.69 47.85 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.029 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 15.3 mm -84.65 113.82 23.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 C-N-CA 120.224 -0.59 . . . . 0.0 109.789 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -149.13 114.88 5.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.172 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 49.1 21.42 0.49 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.49 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.83 29.53 26.02 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' A' ' 19' ' ' CYS . 99.7 mtt180 -124.88 122.24 36.82 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.819 0.342 . . . . 0.0 110.932 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.4 mt -80.27 162.56 24.54 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.736 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.533 ' CE3' ' O ' ' A' ' 17' ' ' GLY . 1.7 t90 -97.02 116.5 29.33 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.026 0.441 . . . . 0.0 110.022 178.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.446 ' O ' ' CD1' ' A' ' 26' ' ' TRP . . . -96.53 151.73 19.3 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.427 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 47.0 t80 -75.94 101.07 5.05 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 118.736 -1.186 . . . . 0.0 108.612 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.621 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 61.4 m -96.16 144.12 26.68 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.869 -178.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 2.6 m . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.399 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.572 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 4.9 m . . . . . 0 CA--C 1.503 -0.863 0 CA-C-O 121.622 0.725 . . . . 0.0 110.67 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -93.41 -171.49 2.65 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.566 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 5.8 t -87.96 -176.92 5.63 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' ' 25' ' ' LEU . 72.5 ttt180 -94.89 111.99 23.74 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 122.333 1.063 . . . . 0.0 109.894 -178.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.558 ' O ' ' N ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -126.94 131.47 23.89 Favored Pre-proline 0 C--N 1.304 -1.394 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 177.383 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -46.93 95.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.301 -1.941 0 CA-C-N 120.894 1.355 . . . . 0.0 110.086 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.635 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -153.58 -164.35 1.87 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.008 -177.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.552 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 26.9 p -54.37 75.97 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.635 ' N ' ' O ' ' A' ' 8' ' ' ALA . 8.7 tp -69.77 -39.71 78.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.35 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.16 172.14 0.87 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.477 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.95 -24.34 28.98 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 -162.3 153.97 18.46 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 90.9 mtm-85 -103.25 155.83 18.16 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.018 0.437 . . . . 0.0 110.7 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 53.3 ptt85 -87.63 140.56 29.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.937 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -108.1 -65.15 1.14 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.092 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 26' ' ' TRP . . . -98.57 166.28 21.67 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.69 124.52 22.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.918 0.39 . . . . 0.0 110.663 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.566 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 14.1 p -101.09 130.04 47.07 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.0 mm -95.33 116.32 36.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.016 0.436 . . . . 0.0 109.943 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -166.45 126.87 1.65 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.434 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 55.69 12.54 0.84 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.176 0.512 . . . . 0.0 109.858 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.89 26.09 42.89 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.648 -0.581 . . . . 0.0 111.648 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.466 ' O ' ' O ' ' A' ' 19' ' ' CYS . 90.4 mtm180 -118.14 137.25 53.09 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.729 0.3 . . . . 0.0 110.634 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.826 HD22 ' N ' ' A' ' 25' ' ' LEU . 0.7 OUTLIER -96.87 164.72 12.43 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.775 -179.292 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.478 ' CZ2' ' O ' ' A' ' 2' ' ' CYS . 25.8 t-105 -101.39 109.23 21.04 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 121.105 0.478 . . . . 0.0 111.167 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -114.83 147.72 39.47 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 176.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.404 ' CD2' ' SG ' ' A' ' 2' ' ' CYS . 9.3 m-85 -78.63 101.12 7.3 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.552 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 8.4 t -117.83 123.48 46.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.751 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.572 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 0.9 OUTLIER . . . . . 0 C--O 1.221 -0.437 0 CA-C-O 117.809 -1.091 . . . . 0.0 109.802 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.58 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 93.1 m . . . . . 0 CA--C 1.519 -0.239 0 CA-C-O 121.159 0.504 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -92.55 152.59 19.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.768 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 3.5 m -88.24 151.2 22.82 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.471 HH21 HG21 ' A' ' 10' ' ' ILE . 2.4 tpt180 -130.69 173.44 10.91 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 122.149 0.976 . . . . 0.0 111.363 -178.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.648 ' O ' ' N ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER -100.74 164.37 16.29 Favored Pre-proline 0 C--N 1.312 -1.03 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 177.059 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.401 ' HA ' ' HB2' ' A' ' 27' ' ' ALA . 74.7 Cg_exo -46.2 75.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.301 -1.935 0 C-N-CA 122.467 2.111 . . . . 0.0 114.057 -176.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.648 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -174.91 109.16 0.11 Allowed 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 113.551 -1.659 . . . . 0.0 108.61 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.526 ' SG ' ' O ' ' A' ' 13' ' ' GLU . 5.1 m -72.0 68.33 0.68 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.471 HG21 HH21 ' A' ' 5' ' ' ARG . 57.6 mt -68.88 -22.74 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-N 113.991 -1.459 . . . . 0.0 110.743 -178.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.503 ' HB2' ' C ' ' A' ' 30' ' ' CYS . . . -84.45 -43.69 14.38 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.236 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.5 41.67 1.12 Allowed Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.542 ' OE1' ' SG ' ' A' ' 30' ' ' CYS . 12.5 pt-20 -146.78 -173.91 4.34 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 81.5 mtm-85 -101.04 149.48 23.89 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.003 0.43 . . . . 0.0 112.137 -178.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.415 ' HB2' ' H ' ' A' ' 28' ' ' PHE . 47.0 ptt85 -91.09 128.66 37.0 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.859 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 91.9 t80 -147.22 -72.48 0.22 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.18 81.42 1.59 Allowed Glycine 0 CA--C 1.524 0.609 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.8 t -110.03 158.44 18.27 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.183 0.516 . . . . 0.0 110.647 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 0.7 OUTLIER -100.71 148.91 24.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.26 179.673 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.6 mm -94.27 119.0 41.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.019 0.437 . . . . 0.0 110.403 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -130.65 142.01 50.43 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.871 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 56.58 12.29 1.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.604 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.27 -1.16 71.67 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -93.09 149.99 20.84 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.641 0.258 . . . . 0.0 110.52 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.542 ' N ' HD12 ' A' ' 25' ' ' LEU . 10.7 mp -77.48 139.23 39.59 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.986 0.422 . . . . 0.0 110.315 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -109.63 142.24 41.04 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.668 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 5' ' ' ARG . . . -87.22 114.36 23.77 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 175.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.415 ' H ' ' HB2' ' A' ' 15' ' ' ARG . 13.7 t80 -75.82 99.87 4.58 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 118.062 -1.455 . . . . 0.0 107.19 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.505 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 1.2 m -141.35 123.62 15.68 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 113.515 -1.675 . . . . 0.0 108.932 -178.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.58 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 46.0 m . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 117.895 -1.05 . . . . 0.0 111.605 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.552 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 70.7 m . . . . . 0 N--CA 1.464 0.23 0 CA-C-O 120.824 0.345 . . . . 0.0 110.845 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.478 ' CD2' ' O ' ' A' ' 4' ' ' CYS . 58.7 t80 -92.4 152.18 19.86 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.564 ' HG ' ' HG ' ' A' ' 19' ' ' CYS . 33.6 m -88.48 148.52 24.13 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.823 0.344 . . . . 0.0 110.92 -178.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.408 ' HG3' ' H ' ' A' ' 6' ' ' ILE . 1.9 tpt180 -156.09 178.03 10.75 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.86 0.838 . . . . 0.0 111.041 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.662 ' O ' ' N ' ' A' ' 8' ' ' ALA . 0.7 OUTLIER -94.84 166.75 14.41 Favored Pre-proline 0 N--CA 1.439 -1.012 0 N-CA-C 103.318 -2.845 . . . . 0.0 103.318 177.216 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -50.86 54.88 0.02 OUTLIER 'Trans proline' 0 N--CA 1.507 2.317 0 C-N-CA 122.425 2.083 . . . . 0.0 115.88 -176.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.662 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -175.14 101.82 0.08 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.77 -0.196 . . . . 0.0 110.808 177.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.514 ' O ' ' SG ' ' A' ' 9' ' ' CYS . 35.4 t 151.36 -8.24 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.564 HD11 ' HB1' ' A' ' 27' ' ' ALA . 8.3 mt -68.3 125.37 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 CA-C-N 114.277 -1.328 . . . . 0.0 109.585 -177.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.24 12.77 0.85 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.508 ' H ' ' C ' ' A' ' 10' ' ' ILE . . . 114.09 80.11 0.92 Allowed Glycine 0 CA--C 1.527 0.812 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.041 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -161.88 168.42 23.04 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 85.1 mmt-85 -103.78 158.82 16.13 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.962 0.411 . . . . 0.0 111.026 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.574 ' HA ' ' H ' ' A' ' 28' ' ' PHE . 33.2 ptt180 -70.71 127.65 33.38 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.492 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.503 ' CD2' ' N ' ' A' ' 17' ' ' GLY . 90.4 t80 -147.41 -91.16 0.09 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.574 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.503 ' N ' ' CD2' ' A' ' 16' ' ' TYR . . . -93.6 88.57 1.24 Allowed Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.415 HG22 ' H ' ' A' ' 19' ' ' CYS . 3.1 m -135.15 166.19 23.65 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.564 ' HG ' ' HG ' ' A' ' 4' ' ' CYS . 1.9 m -98.82 144.0 28.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.78 0.324 . . . . 0.0 110.17 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.408 HG23 ' O ' ' A' ' 24' ' ' ARG . 17.3 mm -96.73 120.95 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.648 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -114.14 136.59 52.77 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.544 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 59.76 12.18 2.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.202 0.525 . . . . 0.0 110.144 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.4 15.33 81.58 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.408 ' O ' HG23 ' A' ' 20' ' ' ILE . 89.8 mtm180 -92.57 152.76 19.43 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.622 0.249 . . . . 0.0 110.348 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.2 mt -76.84 124.05 27.14 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.24 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 6.9 m0 -111.35 143.12 42.65 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.318 0.58 . . . . 0.0 110.508 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.564 ' HB1' HD11 ' A' ' 10' ' ' ILE . . . -92.58 151.08 20.33 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.574 ' H ' ' HA ' ' A' ' 15' ' ' ARG . 61.5 t80 -80.04 105.07 11.04 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.536 0.684 . . . . 0.0 109.579 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.456 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 5.4 t -94.35 130.03 40.82 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.036 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.552 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 6.9 t . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.404 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' CYS . . . . . 0.517 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 24.8 p . . . . . 0 N--CA 1.462 0.134 0 CA-C-O 120.698 0.285 . . . . 0.0 110.282 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.484 ' O ' ' CD2' ' A' ' 3' ' ' TYR . 15.3 p90 -148.0 69.17 1.11 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.083 0.468 . . . . 0.0 110.481 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 2.1 m -153.19 172.89 16.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.845 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ARG . . . . . 0.771 ' C ' HD12 ' A' ' 6' ' ' ILE . 0.6 OUTLIER -101.9 131.56 48.19 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 177.463 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.771 HD12 ' C ' ' A' ' 5' ' ' ARG . 4.1 mp -145.52 131.74 9.67 Favored Pre-proline 0 C--N 1.304 -1.379 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -47.79 87.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.302 -1.902 0 N-CA-C 109.442 -1.022 . . . . 0.0 109.442 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.66 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -167.76 -160.9 0.36 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.239 -176.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.503 ' O ' ' SG ' ' A' ' 9' ' ' CYS . 28.4 p -54.63 70.46 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.444 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.597 ' N ' ' O ' ' A' ' 8' ' ' ALA . 47.2 mt -68.23 -43.06 84.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.711 0.291 . . . . 0.0 110.446 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.57 171.9 4.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.697 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.98 -15.37 63.56 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.629 -0.989 . . . . 0.0 110.629 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 51.0 tp10 -157.67 147.17 20.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.814 0.34 . . . . 0.0 110.291 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.401 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 90.9 mtm-85 -103.41 169.19 8.69 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.504 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -68.51 134.02 49.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.218 0.532 . . . . 0.0 110.985 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' TYR . . . . . 0.401 ' CD2' ' O ' ' A' ' 14' ' ' ARG . 73.2 m-85 -147.19 -106.87 0.09 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.258 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.27 45.7 0.98 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.401 ' H ' ' C ' ' A' ' 16' ' ' TYR . 4.3 p -79.58 165.62 22.75 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 1.2 p -99.18 149.59 22.91 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 19.6 mm -80.4 122.11 35.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.267 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -147.99 145.22 28.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.241 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 52.33 12.75 0.24 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.717 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.59 20.11 78.67 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -136.32 152.26 50.48 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.756 0.312 . . . . 0.0 110.616 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 59.7 mt -82.36 130.51 35.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.117 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.42 ' HB3' ' H ' ' A' ' 5' ' ' ARG . 40.8 m0 -88.97 132.86 34.53 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.57 141.23 48.68 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -79.47 104.42 10.06 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.506 ' O ' ' SG ' ' A' ' 30' ' ' CYS . 44.8 t -94.47 134.6 36.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.977 -179.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.517 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 1.3 m . . . . . 0 C--O 1.221 -0.406 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.977 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.559 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 7.4 m -100.86 140.93 34.46 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-O 121.187 0.517 . . . . 0.0 110.461 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -92.63 -168.14 1.9 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.307 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.497 ' O ' HD13 ' A' ' 6' ' ' ILE . 0.7 OUTLIER -85.41 -174.67 5.32 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.593 -0.731 . . . . 0.0 110.139 -179.461 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 73.1 ttt180 -94.28 112.27 24.05 Favored 'General case' 0 CA--C 1.499 -1.005 0 CA-C-O 121.246 0.546 . . . . 0.0 109.829 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.65 ' O ' ' N ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -136.67 139.33 28.87 Favored Pre-proline 0 N--CA 1.439 -0.993 0 CA-C-N 114.861 -1.063 . . . . 0.0 108.299 179.079 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -46.04 72.65 0.01 OUTLIER 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.685 2.257 . . . . 0.0 112.685 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.65 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -143.33 -163.31 1.62 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.44 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.51 ' O ' ' SG ' ' A' ' 9' ' ' CYS . 29.9 p -58.63 69.81 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.609 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.586 ' N ' ' O ' ' A' ' 8' ' ' ALA . 86.6 mt -77.75 -21.12 13.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.3 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.445 ' O ' ' O ' ' A' ' 10' ' ' ILE . . . -54.01 -164.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.608 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.8 -59.44 2.58 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 110.781 -0.928 . . . . 0.0 110.781 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.504 ' N ' ' OE1' ' A' ' 13' ' ' GLU . 58.0 mp0 -143.76 149.62 37.38 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.024 0.44 . . . . 0.0 110.562 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 28.5 mmt180 -127.35 116.56 20.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.079 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.518 ' NE ' ' CH2' ' A' ' 26' ' ' TRP . 14.3 tpt180 -78.61 137.85 38.05 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.259 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -84.84 -40.66 16.87 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.682 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -70.91 155.22 52.72 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.442 -1.063 . . . . 0.0 110.442 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.3 p -126.82 142.28 51.59 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.658 0.266 . . . . 0.0 110.373 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.518 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 12.9 p -102.46 119.23 38.47 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.217 0.532 . . . . 0.0 110.394 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.4 mm -90.23 96.8 6.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.156 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -146.89 106.09 3.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.107 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 40.2 tp60 63.6 14.29 7.98 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.051 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 84.23 33.69 19.54 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.491 ' O ' ' SG ' ' A' ' 19' ' ' CYS . 96.1 mtt-85 -131.06 121.06 24.33 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.176 0.512 . . . . 0.0 110.574 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.434 HD23 ' N ' ' A' ' 25' ' ' LEU . 4.0 mt -87.38 167.1 14.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.41 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.605 ' CG ' ' O ' ' A' ' 26' ' ' TRP . 1.2 p-90 -113.73 109.94 19.37 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-O 121.572 0.701 . . . . 0.0 111.268 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -95.67 159.69 14.86 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -75.31 102.13 4.97 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 119.722 -0.791 . . . . 0.0 109.098 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.482 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 7.9 t -122.42 122.8 39.84 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.991 -179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.559 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 44.4 m . . . . . 0 C--O 1.22 -0.466 0 CA-C-O 118.112 -0.947 . . . . 0.0 110.372 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.575 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 20.6 p -157.07 151.29 25.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.538 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.48 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 7.9 p90 -139.45 66.18 1.41 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 121.196 0.522 . . . . 0.0 111.15 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -154.49 174.53 14.79 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.396 177.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 70.9 ttp85 -99.43 114.74 27.85 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 121.67 0.748 . . . . 0.0 109.161 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.845 ' H ' HD12 ' A' ' 6' ' ' ILE . 0.1 OUTLIER -137.19 133.11 18.26 Favored Pre-proline 0 C--N 1.305 -1.332 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 -179.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -47.19 85.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.302 -1.881 0 CA-C-N 119.725 0.938 . . . . 0.0 110.691 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.656 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -150.08 -164.83 2.11 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.491 -178.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.494 ' O ' ' SG ' ' A' ' 9' ' ' CYS . 29.1 p -56.66 68.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 O-C-N 123.354 0.409 . . . . 0.0 111.162 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.598 ' N ' ' O ' ' A' ' 8' ' ' ALA . 4.9 mm -69.6 -25.44 28.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.753 0.311 . . . . 0.0 110.393 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.72 171.54 13.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.501 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.03 -17.79 58.61 Favored Glycine 0 CA--C 1.524 0.596 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.548 ' OE2' ' CG ' ' A' ' 28' ' ' PHE . 72.6 tt0 -161.0 160.79 31.1 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 83.0 mmt-85 -103.39 157.26 17.15 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.133 0.492 . . . . 0.0 111.095 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.608 ' NH2' HG21 ' A' ' 18' ' ' THR . 9.3 ptm180 -84.04 140.24 31.97 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.85 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.616 ' O ' HG23 ' A' ' 18' ' ' THR . 84.8 t80 -146.65 -95.33 0.09 Allowed 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.621 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.542 ' N ' ' CD2' ' A' ' 16' ' ' TYR . . . -60.56 77.04 0.01 OUTLIER Glycine 0 CA--C 1.522 0.499 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.616 HG23 ' O ' ' A' ' 16' ' ' TYR . 60.1 p -79.9 164.08 23.82 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.894 -0.323 . . . . 0.0 111.324 -178.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.44 ' H ' ' HB3' ' A' ' 26' ' ' TRP . 14.1 p -118.71 126.18 51.32 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.207 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.453 ' H ' HD12 ' A' ' 20' ' ' ILE . 5.4 mp -86.62 97.71 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.418 ' C ' ' N ' ' A' ' 23' ' ' GLY . 67.6 m-85 -146.35 143.82 29.36 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.438 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 50.17 15.61 0.2 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.8 0.333 . . . . 0.0 110.586 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.418 ' N ' ' C ' ' A' ' 21' ' ' TYR . . . 76.13 25.67 65.89 Favored Glycine 0 CA--C 1.526 0.767 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -128.26 140.95 51.61 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.986 0.422 . . . . 0.0 110.944 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.771 ' N ' HD22 ' A' ' 25' ' ' LEU . 2.2 mm? -89.62 157.85 17.86 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.529 179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.541 ' CE3' ' O ' ' A' ' 17' ' ' GLY . 1.7 t90 -102.53 114.26 28.32 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.513 ' O ' ' CD1' ' A' ' 26' ' ' TRP . . . -89.42 152.69 21.35 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 177.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.548 ' CG ' ' OE2' ' A' ' 13' ' ' GLU . 0.8 OUTLIER -75.88 102.65 5.62 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 118.685 -1.206 . . . . 0.0 108.718 -178.547 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.44 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 12.9 t -108.0 153.83 22.52 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 114.468 -1.242 . . . . 0.0 110.318 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.575 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 2.6 m . . . . . 0 C--O 1.219 -0.507 0 CA-C-O 117.843 -1.075 . . . . 0.0 110.425 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 10.7 t -100.48 124.52 46.12 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.769 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.531 ' CD2' ' O ' ' A' ' 4' ' ' CYS . 56.8 t80 -102.99 151.5 22.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.346 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.553 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 2.7 m -88.17 154.08 20.73 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.595 HH21 HG21 ' A' ' 10' ' ' ILE . 3.5 tpt180 -138.06 174.17 10.85 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-O 122.029 0.919 . . . . 0.0 111.99 -178.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.628 ' O ' ' N ' ' A' ' 8' ' ' ALA . 1.9 pt -99.73 162.14 22.11 Favored Pre-proline 0 N--CA 1.44 -0.954 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 177.077 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.499 ' HA ' ' HB2' ' A' ' 27' ' ' ALA . 93.0 Cg_exo -47.86 76.27 0.01 OUTLIER 'Trans proline' 0 N--CA 1.5 1.867 0 C-N-CA 122.113 1.875 . . . . 0.0 113.813 -177.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.628 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -175.02 110.36 0.12 Allowed 'General case' 0 N--CA 1.434 -1.245 0 CA-C-N 114.015 -1.448 . . . . 0.0 109.16 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.539 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 55.8 m -70.46 70.3 0.42 Allowed 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 178.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.595 HG21 HH21 ' A' ' 5' ' ' ARG . 66.2 mt -66.28 -42.82 91.5 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 CA-C-N 114.154 -1.384 . . . . 0.0 110.166 -178.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.22 -39.36 17.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.54 179.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.73 78.76 0.85 Allowed Glycine 0 CA--C 1.529 0.921 0 N-CA-C 111.815 -0.514 . . . . 0.0 111.815 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.516 ' O ' ' SG ' ' A' ' 9' ' ' CYS . 2.5 mm-40 -162.18 -179.18 6.86 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.987 0.422 . . . . 0.0 110.098 179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 95.7 mtt-85 -103.99 136.41 43.69 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.751 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.418 ' H ' ' HG2' ' A' ' 15' ' ' ARG . 31.7 ptt-85 -75.49 132.08 40.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.445 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.473 ' H ' ' HB3' ' A' ' 28' ' ' PHE . 29.8 m-85 -148.55 -103.29 0.08 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.09 65.79 1.22 Allowed Glycine 0 CA--C 1.523 0.574 0 N-CA-C 110.386 -1.085 . . . . 0.0 110.386 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 26' ' ' TRP . 8.9 t -79.43 163.94 24.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.963 0.411 . . . . 0.0 110.746 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.553 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 2.3 m -101.4 154.07 19.12 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.786 179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 18.6 mm -96.0 116.29 37.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 120.957 0.408 . . . . 0.0 110.577 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -121.98 133.23 54.82 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.27 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 52.32 13.74 0.31 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.728 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 81.79 4.44 90.33 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.819 -0.912 . . . . 0.0 110.819 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.4 tpt180 -92.89 146.03 23.94 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.561 ' N ' HD22 ' A' ' 25' ' ' LEU . 3.4 mm? -76.86 136.24 38.88 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.119 0.485 . . . . 0.0 110.342 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.435 ' O ' ' OG1' ' A' ' 18' ' ' THR . 3.8 m95 -111.59 143.89 41.72 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.597 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.499 ' HB2' ' HA ' ' A' ' 7' ' ' PRO . . . -90.42 118.53 29.97 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 175.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.473 ' HB3' ' H ' ' A' ' 16' ' ' TYR . 26.0 t80 -76.99 100.03 5.49 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.539 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 1.3 m -130.13 126.28 37.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.46 -1.245 . . . . 0.0 109.43 -178.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 69.1 m . . . . . 0 C--O 1.218 -0.57 0 CA-C-O 118.101 -0.952 . . . . 0.0 111.556 -178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.581 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 16.7 p -152.85 158.7 42.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.303 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.503 ' CD2' ' O ' ' A' ' 3' ' ' TYR . 18.8 p90 -139.61 68.63 1.37 Allowed 'General case' 0 N--CA 1.463 0.184 0 CA-C-O 121.485 0.659 . . . . 0.0 110.773 179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.478 ' C ' ' CD1' ' A' ' 26' ' ' TRP . 0.8 OUTLIER -151.28 179.14 8.57 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.303 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.487 HH11 ' CB ' ' A' ' 27' ' ' ALA . 57.7 ttt85 -95.59 122.36 38.26 Favored 'General case' 0 CA--C 1.489 -1.396 0 CA-C-O 122.485 1.136 . . . . 0.0 109.672 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.897 ' N ' HD13 ' A' ' 6' ' ' ILE . 0.0 OUTLIER -104.37 158.24 32.36 Favored Pre-proline 0 N--CA 1.416 -2.174 0 N-CA-C 102.58 -3.119 . . . . 0.0 102.58 176.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -61.82 24.66 0.05 OUTLIER 'Trans proline' 0 C--N 1.274 -3.346 0 C-N-CA 121.08 1.187 . . . . 0.0 111.985 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.665 ' H ' ' C ' ' A' ' 6' ' ' ILE . . . -155.27 108.91 2.83 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.544 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -62.85 99.29 0.15 Allowed 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 117.581 -1.648 . . . . 0.0 106.827 178.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.422 ' HB ' ' H ' ' A' ' 30' ' ' CYS . 96.3 mt -65.08 -43.46 95.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.894 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.317 -176.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.424 ' H ' ' HA ' ' A' ' 29' ' ' CYS . . . -77.52 -22.12 51.65 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.346 -0.541 . . . . 0.0 111.147 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 66.71 30.48 76.35 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 -178.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.551 ' OE1' ' CD1' ' A' ' 28' ' ' PHE . 83.1 mt-10 -100.79 -175.82 3.0 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 121.367 0.603 . . . . 0.0 111.358 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 85.8 mtp180 -101.03 143.5 31.09 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.765 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.578 ' HD2' ' H ' ' A' ' 15' ' ' ARG . 0.0 OUTLIER -68.41 142.13 55.49 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.297 -179.352 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.537 ' CD2' ' N ' ' A' ' 17' ' ' GLY . 70.6 t80 -148.63 -99.15 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.886 0.374 . . . . 0.0 110.868 179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.537 ' N ' ' CD2' ' A' ' 16' ' ' TYR . . . -79.43 68.51 3.15 Favored Glycine 0 CA--C 1.52 0.347 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.442 HG22 ' O ' ' A' ' 26' ' ' TRP . 6.3 p -80.49 165.33 22.26 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.091 0.472 . . . . 0.0 111.991 -178.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.472 ' H ' ' HB3' ' A' ' 26' ' ' TRP . 9.4 p -100.03 139.22 36.01 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.518 -0.764 . . . . 0.0 109.126 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 21.0 mm -78.39 122.85 34.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.998 0.428 . . . . 0.0 110.316 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . 0.424 ' C ' ' N ' ' A' ' 23' ' ' GLY . 86.5 t80 -153.53 128.69 9.71 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.582 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 43.2 tp60 51.87 12.39 0.19 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.07 0.462 . . . . 0.0 110.213 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.424 ' N ' ' C ' ' A' ' 21' ' ' TYR . . . 86.39 -2.26 87.44 Favored Glycine 0 CA--C 1.525 0.704 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -98.26 135.1 40.37 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 110.225 -0.287 . . . . 0.0 110.225 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 76.1 mt -80.92 138.33 36.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.157 0.503 . . . . 0.0 110.562 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.701 ' CD1' ' O ' ' A' ' 27' ' ' ALA . 0.3 OUTLIER -77.78 111.72 13.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.861 179.146 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.701 ' O ' ' CD1' ' A' ' 26' ' ' TRP . . . -66.39 149.14 50.84 Favored 'General case' 0 C--O 1.218 -0.605 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 178.037 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.551 ' CD1' ' OE1' ' A' ' 13' ' ' GLU . 3.0 t80 -73.24 104.07 4.16 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 118.691 -1.204 . . . . 0.0 110.027 -178.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.424 ' HA ' ' H ' ' A' ' 11' ' ' ALA . 12.7 m -122.29 164.85 17.18 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 113.382 -1.735 . . . . 0.0 109.292 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.581 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 5.2 m . . . . . 0 C--O 1.22 -0.497 0 CA-C-O 118.01 -0.995 . . . . 0.0 111.027 -179.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.48 ' SG ' ' N ' ' A' ' 16' ' ' TYR . 8.0 t -101.81 176.45 5.21 Favored 'General case' 0 CA--C 1.512 -0.486 0 CA-C-O 121.315 0.579 . . . . 0.0 110.988 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.552 ' N ' ' SG ' ' A' ' 30' ' ' CYS . 58.6 m-85 -131.45 151.58 51.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.248 179.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.584 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 56.7 m -87.78 -175.13 5.04 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.839 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . . . . . . . . . 51.4 ttt85 -92.11 114.72 27.33 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 122.743 1.259 . . . . 0.0 111.065 -178.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.6 ' O ' ' N ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -139.44 129.95 14.49 Favored Pre-proline 0 N--CA 1.426 -1.645 0 N-CA-C 103.268 -2.864 . . . . 0.0 103.268 176.097 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -47.4 90.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.295 -2.257 0 CA-C-N 121.002 1.394 . . . . 0.0 110.893 -177.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.6 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -146.85 -161.44 1.33 Allowed 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 114.558 -1.201 . . . . 0.0 109.792 -177.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.57 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 28.2 p -57.52 76.76 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.356 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.575 ' N ' ' O ' ' A' ' 8' ' ' ALA . 52.5 mt -68.66 -18.54 23.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.59 -164.67 1.16 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.028 179.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.06 -102.96 2.44 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.405 ' HG2' ' N ' ' A' ' 14' ' ' ARG . 77.6 tt0 -100.78 167.07 10.54 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.405 ' N ' ' HG2' ' A' ' 13' ' ' GLU . 85.1 mtm-85 -101.3 162.97 12.51 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.09 0.472 . . . . 0.0 110.921 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 2.8 ptm180 -67.29 134.56 51.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.874 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.48 ' N ' ' SG ' ' A' ' 2' ' ' CYS . 88.0 t80 -85.74 -15.56 41.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.292 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 178.03 110.02 0.26 Allowed Glycine 0 CA--C 1.526 0.727 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.459 ' H ' HG22 ' A' ' 18' ' ' THR . 0.0 OUTLIER -79.25 144.22 34.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.819 0.343 . . . . 0.0 110.63 -179.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.584 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 25.8 p -133.29 118.43 18.53 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.103 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 96.5 mt -87.98 139.15 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.475 0 CA-C-O 121.194 0.521 . . . . 0.0 110.877 -179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -149.47 115.15 5.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.493 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 50.56 33.77 8.52 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.699 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 90.69 36.03 7.03 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 120.899 -0.667 . . . . 0.0 111.784 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.422 ' C ' HD22 ' A' ' 25' ' ' LEU . 60.7 ttm-85 -90.41 132.38 35.65 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 121.238 0.542 . . . . 0.0 110.719 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.595 HD22 ' N ' ' A' ' 25' ' ' LEU . 3.6 mm? -95.64 163.15 13.32 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.538 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.413 ' CD1' ' OG1' ' A' ' 18' ' ' THR . 61.8 p-90 -122.16 138.91 54.3 Favored 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 122.074 0.94 . . . . 0.0 110.874 178.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -115.58 160.41 20.02 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 113.695 -1.593 . . . . 0.0 107.974 178.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.464 ' O ' ' O ' ' A' ' 10' ' ' ILE . 85.7 m-85 -75.22 100.76 4.42 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 178.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.57 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 8.6 t -139.01 -173.25 3.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.173 -176.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.552 ' SG ' ' N ' ' A' ' 3' ' ' TYR . 2.7 m . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 117.897 -1.049 . . . . 0.0 110.626 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 5.6 p -151.95 136.72 17.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.247 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.411 ' C ' ' CD1' ' A' ' 26' ' ' TRP . 42.1 m-85 -125.37 66.91 1.14 Allowed 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.89 0.376 . . . . 0.0 110.641 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.557 ' O ' ' SG ' ' A' ' 29' ' ' CYS . 0.0 OUTLIER -153.37 173.68 15.33 Favored 'General case' 0 C--O 1.214 -0.764 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.707 HH11 ' NH2' ' A' ' 15' ' ' ARG . 62.4 ttp180 -100.09 111.47 23.76 Favored 'General case' 0 CA--C 1.479 -1.782 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.552 ' O ' ' N ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -108.39 158.78 32.95 Favored Pre-proline 0 C--N 1.299 -1.605 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 178.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -48.9 -6.18 0.05 OUTLIER 'Trans proline' 0 C--N 1.28 -3.069 0 C-N-CA 120.76 0.974 . . . . 0.0 112.193 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -127.41 105.79 8.76 Favored 'General case' 0 CA--C 1.514 -0.43 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.299 179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.621 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 1.7 p 155.25 5.19 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 36.1 mm -66.73 -42.51 89.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 C-N-CA 119.624 -0.831 . . . . 0.0 109.112 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -101.76 154.41 18.93 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.881 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.83 6.2 85.54 Favored Glycine 0 N--CA 1.466 0.649 0 N-CA-C 111.086 -0.806 . . . . 0.0 111.086 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.55 ' CG ' ' O ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER -163.22 -176.8 5.0 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.815 0.34 . . . . 0.0 110.588 -179.002 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 95.4 mtt180 -131.82 152.67 50.83 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.682 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.707 ' NH2' HH11 ' A' ' 5' ' ' ARG . 42.0 ttm180 -86.21 100.43 12.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.808 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -102.08 -101.7 0.27 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.88 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.533 ' O ' ' CE3' ' A' ' 26' ' ' TRP . . . -59.22 112.32 4.12 Favored Glycine 0 N--CA 1.452 -0.292 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.477 ' HA ' ' H ' ' A' ' 26' ' ' TRP . 0.1 OUTLIER -102.44 123.8 46.85 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.951 0.405 . . . . 0.0 110.419 -179.488 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.497 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 7.3 p -101.72 131.69 47.85 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.029 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 15.3 mm -84.65 113.82 23.93 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 C-N-CA 120.224 -0.59 . . . . 0.0 109.789 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -149.13 114.88 5.65 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.172 -179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 49.1 21.42 0.49 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.49 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 85.83 29.53 26.02 Favored Glycine 0 CA--C 1.527 0.821 0 N-CA-C 111.523 -0.631 . . . . 0.0 111.523 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.449 ' O ' ' O ' ' A' ' 19' ' ' CYS . 99.7 mtt180 -124.88 122.24 36.82 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.819 0.342 . . . . 0.0 110.932 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 9.4 mt -80.27 162.56 24.54 Favored 'General case' 0 C--O 1.222 -0.364 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.736 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.533 ' CE3' ' O ' ' A' ' 17' ' ' GLY . 1.7 t90 -97.02 116.5 29.33 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.026 0.441 . . . . 0.0 110.022 178.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.446 ' O ' ' CD1' ' A' ' 26' ' ' TRP . . . -96.53 151.73 19.3 Favored 'General case' 0 CA--C 1.511 -0.553 0 N-CA-C 107.289 -1.374 . . . . 0.0 107.289 177.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.427 ' O ' ' OE1' ' A' ' 13' ' ' GLU . 47.0 t80 -75.94 101.07 5.05 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 118.736 -1.186 . . . . 0.0 108.612 -178.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.621 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 61.4 m -96.16 144.12 26.68 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 114.333 -1.303 . . . . 0.0 110.869 -178.135 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.569 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 2.6 m . . . . . 0 C--O 1.22 -0.449 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.399 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.652 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.572 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 4.9 m -100.04 142.79 31.04 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-O 121.622 0.725 . . . . 0.0 110.67 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -93.41 -171.49 2.65 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.566 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 5.8 t -87.96 -176.92 5.63 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.412 ' N ' ' O ' ' A' ' 25' ' ' LEU . 72.5 ttt180 -94.89 111.99 23.74 Favored 'General case' 0 CA--C 1.503 -0.829 0 CA-C-O 122.333 1.063 . . . . 0.0 109.894 -178.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.558 ' O ' ' N ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -126.94 131.47 23.89 Favored Pre-proline 0 C--N 1.304 -1.394 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 177.383 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -46.93 95.39 0.03 OUTLIER 'Trans proline' 0 C--N 1.301 -1.941 0 CA-C-N 120.894 1.355 . . . . 0.0 110.086 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.635 ' O ' ' N ' ' A' ' 10' ' ' ILE . . . -153.58 -164.35 1.87 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.008 -177.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.552 ' SG ' ' SG ' ' A' ' 29' ' ' CYS . 26.9 p -54.37 75.97 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.635 ' N ' ' O ' ' A' ' 8' ' ' ALA . 8.7 tp -69.77 -39.71 78.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.35 -178.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.16 172.14 0.87 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.477 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.95 -24.34 28.98 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 -162.3 153.97 18.46 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 90.9 mtm-85 -103.25 155.83 18.16 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.018 0.437 . . . . 0.0 110.7 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 53.3 ptt85 -87.63 140.56 29.39 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.937 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -108.1 -65.15 1.14 Allowed 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.092 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.403 ' O ' ' O ' ' A' ' 26' ' ' TRP . . . -98.57 166.28 21.67 Favored Glycine 0 CA--C 1.521 0.457 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -136.69 124.52 22.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.918 0.39 . . . . 0.0 110.663 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.566 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 14.1 p -101.09 130.04 47.07 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.0 mm -95.33 116.32 36.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.016 0.436 . . . . 0.0 109.943 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 90.7 t80 -166.45 126.87 1.65 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.434 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 55.69 12.54 0.84 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.176 0.512 . . . . 0.0 109.858 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.89 26.09 42.89 Favored Glycine 0 CA--C 1.527 0.84 0 N-CA-C 111.648 -0.581 . . . . 0.0 111.648 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.466 ' O ' ' O ' ' A' ' 19' ' ' CYS . 90.4 mtm180 -118.14 137.25 53.09 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.729 0.3 . . . . 0.0 110.634 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.826 HD22 ' N ' ' A' ' 25' ' ' LEU . 0.7 OUTLIER -96.87 164.72 12.43 Favored 'General case' 0 C--O 1.221 -0.435 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.775 -179.292 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.478 ' CZ2' ' O ' ' A' ' 2' ' ' CYS . 25.8 t-105 -101.39 109.23 21.04 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-O 121.105 0.478 . . . . 0.0 111.167 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -114.83 147.72 39.47 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 176.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.404 ' CD2' ' SG ' ' A' ' 2' ' ' CYS . 9.3 m-85 -78.63 101.12 7.3 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.552 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 8.4 t -117.83 123.48 46.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.751 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.572 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 0.9 OUTLIER . . . . . 0 C--O 1.221 -0.437 0 CA-C-O 117.809 -1.091 . . . . 0.0 109.802 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.58 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 93.1 m -101.2 128.12 47.45 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-O 121.159 0.504 . . . . 0.0 110.943 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -92.55 152.59 19.54 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.768 179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 3.5 m -88.24 151.2 22.82 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.471 HH21 HG21 ' A' ' 10' ' ' ILE . 2.4 tpt180 -130.69 173.44 10.91 Favored 'General case' 0 CA--C 1.504 -0.792 0 CA-C-O 122.149 0.976 . . . . 0.0 111.363 -178.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.648 ' O ' ' N ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER -100.74 164.37 16.29 Favored Pre-proline 0 C--N 1.312 -1.03 0 N-CA-C 104.609 -2.367 . . . . 0.0 104.609 177.059 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.401 ' HA ' ' HB2' ' A' ' 27' ' ' ALA . 74.7 Cg_exo -46.2 75.31 0.01 OUTLIER 'Trans proline' 0 C--N 1.301 -1.935 0 C-N-CA 122.467 2.111 . . . . 0.0 114.057 -176.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.648 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -174.91 109.16 0.11 Allowed 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 113.551 -1.659 . . . . 0.0 108.61 179.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.526 ' SG ' ' O ' ' A' ' 13' ' ' GLU . 5.1 m -72.0 68.33 0.68 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.471 HG21 HH21 ' A' ' 5' ' ' ARG . 57.6 mt -68.88 -22.74 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-N 113.991 -1.459 . . . . 0.0 110.743 -178.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.503 ' HB2' ' C ' ' A' ' 30' ' ' CYS . . . -84.45 -43.69 14.38 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.236 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.5 41.67 1.12 Allowed Glycine 0 CA--C 1.528 0.861 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.542 ' OE1' ' SG ' ' A' ' 30' ' ' CYS . 12.5 pt-20 -146.78 -173.91 4.34 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 81.5 mtm-85 -101.04 149.48 23.89 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.003 0.43 . . . . 0.0 112.137 -178.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.415 ' HB2' ' H ' ' A' ' 28' ' ' PHE . 47.0 ptt85 -91.09 128.66 37.0 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 115.716 -0.674 . . . . 0.0 109.859 179.149 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . . . . . . . . . 91.9 t80 -147.22 -72.48 0.22 Allowed 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -88.18 81.42 1.59 Allowed Glycine 0 CA--C 1.524 0.609 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.8 t -110.03 158.44 18.27 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.183 0.516 . . . . 0.0 110.647 -179.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 0.7 OUTLIER -100.71 148.91 24.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.26 179.673 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 16.6 mm -94.27 119.0 41.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.019 0.437 . . . . 0.0 110.403 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -130.65 142.01 50.43 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.871 179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 56.58 12.29 1.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.604 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 78.27 -1.16 71.67 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 79.8 mtp85 -93.09 149.99 20.84 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.641 0.258 . . . . 0.0 110.52 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.542 ' N ' HD12 ' A' ' 25' ' ' LEU . 10.7 mp -77.48 139.23 39.59 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.986 0.422 . . . . 0.0 110.315 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 6.1 m95 -109.63 142.24 41.04 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.668 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.425 ' N ' ' O ' ' A' ' 5' ' ' ARG . . . -87.22 114.36 23.77 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 175.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.415 ' H ' ' HB2' ' A' ' 15' ' ' ARG . 13.7 t80 -75.82 99.87 4.58 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 118.062 -1.455 . . . . 0.0 107.19 -179.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.505 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 1.2 m -141.35 123.62 15.68 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 113.515 -1.675 . . . . 0.0 108.932 -178.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.58 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 46.0 m . . . . . 0 C--O 1.22 -0.485 0 CA-C-O 117.895 -1.05 . . . . 0.0 111.605 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.552 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 70.7 m -100.87 131.67 46.64 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.845 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.478 ' CD2' ' O ' ' A' ' 4' ' ' CYS . 58.7 t80 -92.4 152.18 19.86 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.564 ' HG ' ' HG ' ' A' ' 19' ' ' CYS . 33.6 m -88.48 148.52 24.13 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.823 0.344 . . . . 0.0 110.92 -178.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.408 ' HG3' ' H ' ' A' ' 6' ' ' ILE . 1.9 tpt180 -156.09 178.03 10.75 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 121.86 0.838 . . . . 0.0 111.041 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.662 ' O ' ' N ' ' A' ' 8' ' ' ALA . 0.7 OUTLIER -94.84 166.75 14.41 Favored Pre-proline 0 N--CA 1.439 -1.012 0 N-CA-C 103.318 -2.845 . . . . 0.0 103.318 177.216 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -50.86 54.88 0.02 OUTLIER 'Trans proline' 0 N--CA 1.507 2.317 0 C-N-CA 122.425 2.083 . . . . 0.0 115.88 -176.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.662 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -175.14 101.82 0.08 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 116.77 -0.196 . . . . 0.0 110.808 177.055 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.514 ' O ' ' SG ' ' A' ' 9' ' ' CYS . 35.4 t 151.36 -8.24 0.0 OUTLIER 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.564 HD11 ' HB1' ' A' ' 27' ' ' ALA . 8.3 mt -68.3 125.37 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.858 0 CA-C-N 114.277 -1.328 . . . . 0.0 109.585 -177.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.24 12.77 0.85 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.508 ' H ' ' C ' ' A' ' 10' ' ' ILE . . . 114.09 80.11 0.92 Allowed Glycine 0 CA--C 1.527 0.812 0 CA-C-N 115.207 -0.906 . . . . 0.0 111.041 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -161.88 168.42 23.04 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 85.1 mmt-85 -103.78 158.82 16.13 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.962 0.411 . . . . 0.0 111.026 -179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.574 ' HA ' ' H ' ' A' ' 28' ' ' PHE . 33.2 ptt180 -70.71 127.65 33.38 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.492 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.503 ' CD2' ' N ' ' A' ' 17' ' ' GLY . 90.4 t80 -147.41 -91.16 0.09 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.574 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.503 ' N ' ' CD2' ' A' ' 16' ' ' TYR . . . -93.6 88.57 1.24 Allowed Glycine 0 CA--C 1.526 0.743 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.415 HG22 ' H ' ' A' ' 19' ' ' CYS . 3.1 m -135.15 166.19 23.65 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.564 ' HG ' ' HG ' ' A' ' 4' ' ' CYS . 1.9 m -98.82 144.0 28.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.78 0.324 . . . . 0.0 110.17 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.408 HG23 ' O ' ' A' ' 24' ' ' ARG . 17.3 mm -96.73 120.95 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.648 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 72.2 m-85 -114.14 136.59 52.77 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.544 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 59.76 12.18 2.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.202 0.525 . . . . 0.0 110.144 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 76.4 15.33 81.58 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.408 ' O ' HG23 ' A' ' 20' ' ' ILE . 89.8 mtm180 -92.57 152.76 19.43 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.622 0.249 . . . . 0.0 110.348 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 69.2 mt -76.84 124.05 27.14 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.24 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 6.9 m0 -111.35 143.12 42.65 Favored 'General case' 0 CA--C 1.509 -0.602 0 CA-C-O 121.318 0.58 . . . . 0.0 110.508 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.564 ' HB1' HD11 ' A' ' 10' ' ' ILE . . . -92.58 151.08 20.33 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 177.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.574 ' H ' ' HA ' ' A' ' 15' ' ' ARG . 61.5 t80 -80.04 105.07 11.04 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.536 0.684 . . . . 0.0 109.579 -179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.456 ' SG ' ' SG ' ' A' ' 9' ' ' CYS . 5.4 t -94.35 130.03 40.82 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.036 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.552 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 6.9 t . . . . . 0 C--O 1.22 -0.467 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.404 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' CYS . . . . . 0.517 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 24.8 p -152.69 155.11 36.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.282 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.484 ' O ' ' CD2' ' A' ' 3' ' ' TYR . 15.3 p90 -148.0 69.17 1.11 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.083 0.468 . . . . 0.0 110.481 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 19' ' ' CYS . 2.1 m -153.19 172.89 16.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.845 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ARG . . . . . 0.771 ' C ' HD12 ' A' ' 6' ' ' ILE . 0.6 OUTLIER -101.9 131.56 48.19 Favored 'General case' 0 CA--C 1.501 -0.926 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 177.463 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.771 HD12 ' C ' ' A' ' 5' ' ' ARG . 4.1 mp -145.52 131.74 9.67 Favored Pre-proline 0 C--N 1.304 -1.379 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 179.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -47.79 87.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.302 -1.902 0 N-CA-C 109.442 -1.022 . . . . 0.0 109.442 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.66 ' N ' ' O ' ' A' ' 6' ' ' ILE . . . -167.76 -160.9 0.36 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.239 -176.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.503 ' O ' ' SG ' ' A' ' 9' ' ' CYS . 28.4 p -54.63 70.46 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.444 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.597 ' N ' ' O ' ' A' ' 8' ' ' ALA . 47.2 mt -68.23 -43.06 84.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.711 0.291 . . . . 0.0 110.446 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.57 171.9 4.64 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.697 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 94.98 -15.37 63.56 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.629 -0.989 . . . . 0.0 110.629 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 51.0 tp10 -157.67 147.17 20.02 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.814 0.34 . . . . 0.0 110.291 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.401 ' O ' ' CD2' ' A' ' 16' ' ' TYR . 90.9 mtm-85 -103.41 169.19 8.69 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.504 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.3 ptp85 -68.51 134.02 49.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.218 0.532 . . . . 0.0 110.985 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' TYR . . . . . 0.401 ' CD2' ' O ' ' A' ' 14' ' ' ARG . 73.2 m-85 -147.19 -106.87 0.09 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.258 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . -72.27 45.7 0.98 Allowed Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.52 -1.032 . . . . 0.0 110.52 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.401 ' H ' ' C ' ' A' ' 16' ' ' TYR . 4.3 p -79.58 165.62 22.75 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.586 ' SG ' ' SG ' ' A' ' 4' ' ' CYS . 1.2 p -99.18 149.59 22.91 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 19.6 mm -80.4 122.11 35.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.267 -179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -147.99 145.22 28.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.241 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 52.33 12.75 0.24 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.717 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 75.59 20.11 78.67 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 85.5 mtp180 -136.32 152.26 50.48 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 120.756 0.312 . . . . 0.0 110.616 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 59.7 mt -82.36 130.51 35.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.117 -179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.42 ' HB3' ' H ' ' A' ' 5' ' ' ARG . 40.8 m0 -88.97 132.86 34.53 Favored 'General case' 0 CA--C 1.506 -0.715 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.57 141.23 48.68 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -79.47 104.42 10.06 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.506 ' O ' ' SG ' ' A' ' 30' ' ' CYS . 44.8 t -94.47 134.6 36.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.977 -179.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.517 ' SG ' ' SG ' ' A' ' 2' ' ' CYS . 1.3 m . . . . . 0 C--O 1.221 -0.406 0 CA-C-O 117.987 -1.006 . . . . 0.0 109.977 179.924 . . . . . . . . 1 1 . 1 stop_ save_